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ABSTRACT 
Background. Theory of developmental origins of adult health and disease proposes that 
experiences during critical periods of early development may have consequences on 
health throughout a lifespan. Circumstances in utero or during infancy may induce 
changes in body size and structure, metabolism, hormone secretion and gene expression. 
These changes may serve as advantageous adaptations aiming at better survival if 
environmental conditions, such as nutrient availability, remain as predicted in early life. 
If the predictions, however, mismatch with reality, these adaptations may lead to 
increased susceptibility to disturbances in adult health. Low birth weight in subjects born 
at term is a widely used crude indicator of adjustments during fetal life that are 
unfavourable in an affluent society. The aim of these studies was to characterize the 
associations between early growth and some components of the metabolic syndrome 
cluster, and factors that may contribute to and interact with these associations. 
Subjects and methods. Participants of these studies belong to clinically examined subsets 
of two epidemiological cohorts with data on birth measurements and, for the younger 
cohort, on serial recordings of weight and height during childhood. They were born as 
singletons between 1924-33 and 1934-44 in the Helsinki University Central Hospital, 
and 500 and 2003 of them, respectively, attended clinical studies at the age of 65-75 and 
56-70 years, respectively. Their clinical examinations included an oral glucose tolerance 
test, blood pressure (BP) measurements, an analysis of body composition by 
bioelectrical impedance, questionnaires on medication and exercise habits, and 
determination of the Pro12Ala polymorphism of the peroxisome proliferator-activated 
receptor-2 (PPAR2) gene.  
Results. In the 65-75 year old men and women, the inverse relationship between birth 
weight and systolic BP was confined to people who had established hypertension. 
Among them a 1-kg increase in birthweight was associated with a 6.4-mmHg (95% CI: 
1.0 to 11.9) decrease in systolic BP. This inverse relationship was further confined to 
people with the prevailing Pro12Pro polymorphism of the PPAR2 gene (9.3 mmHg/kg, 
95% CI: 2.1-16.4). Low birth weight was related to the use of angiotensin-converting 
enzyme inhibitors/angiotensin-receptor blockers (ACEI/ARB, p=0.03). Again, this 
association interacted significantly with the PPAR2 gene polymorphism, the carriers of 
 
 
the Pro12Pro with low birth weight being more likely to receive ACEI/ARB treatment 
(p=0.01 for interaction). 
A lower rate of glucose intolerance was related to habitual frequent or moderate leisure-
time exercise. This effect was dependent on birth size, being strongest among those with 
a small body size at birth. Among subjects with birth weight 3000 g, the odds ratio 
(OR) for glucose intolerance was 5.2 (95% CI: 2.1 to 13) in those who exercised less 
than 3 times per week compared to regular exercisers; in those who scored their exercise 
light compared with moderate exercisers (defined as comparable to brisk walking) the 
OR was 3.5 (1.5 to 8.2). 
In the 56-70 year old men a 1 kg increase in birth weight corresponded to a 4.1 kg (95% 
CI: 3.1 to 5.1) and in women to a 2.9 kg (2.1 to 3.6) increase in adult lean mass. Height-
normalized indices of adult lean and fat body mass (LMI, lean mass/height squared and 
FMI, fat mass/ height squared) were used in the analyses of associations of body mass 
index (BMI) at birth and change in BMI during four periods of childhood growth with 
adult body composition. Adult LMI was positively associated with BMI at birth (0.24 
and 0.20 kg/m2 higher for each 1 SD increase in BMI at birth in men and in women, 
respectively). Rapid growth, i.e. crossing from an original BMI percentile to a higher 
one, was positively related to adult LMI during all growth periods analysed: rapid gain 
in BMI between birth and 1 year of age, 1-2, 2-7 and 7-11 years resulted in men to a 
0.17, 0.21, 0.44 and 0.32 kg/m2 and in women to a 0.22, 0.20, 0.46 and 0.26 kg/m2 
higher adult LMI, respectively. FMI and percent body fat were positively associated with 
rapid gain in BMI between 2 and 11 years of age. 
Conclusions. These studies suggest that in the 65-75 year old subjects the well-known 
inverse association between birth weight and systolic BP becomes focused in 
hypertensive people because pathological features of BP regulation, associated with slow 
fetal growth, become self-perpetuating in adult life and are amplified by age. Insulin 
resistance of the Pro12Pro carriers with low birth weight may interact with the renin-
angiotensin-aldosterone system leading to raised BP levels. Subjects predisposed to type 
2 diabetes due to their low birth weight are strongly protected from glucose intolerance 
by regular exercise at a moderate intensity. In the 56-70 year old subjects rapid gain in 
BMI before the age of 2 years increased adult lean body mass without excess fat 
accumulation whereas rapid gain in BMI during later childhood, despite the concurrent 
rise in lean mass, resulted in relatively higher increase in adult body fat mass. These 
findings illustrate how genes, the environment and their interactions, early growth 
patterns, and adult lifestyle modify adult health risks which originate from early life. 
Keywords: birth weight, blood pressure, body composition, cohort studies, 
developmental origins, epidemiology, exercise, insulin resistance, peroxisome 
proliferator-activated receptor-2 gene polymorphism, type 2 diabetes 
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TIIVISTELMÄ 
Elämänkaarinäkökulman mukaan aikuisiän terveydentilan tai sairauksien alkuperä voi 
löytyä jo varhaiskehityksestä. Sikiöaikana tai varhaislapsuudessa kehityksen kriittisen 
vaiheen tulevaisuutta ennakoivat olosuhteet voivat aiheuttaa myöhempään 
menestymiseen tähtääviä sopeutumismuutoksia kehon ja elinten koossa ja kasvussa, 
rakenteessa, aineenvaihdunnassa, hormonaalisessa toiminnassa tai geenien 
ilmentymisessä. Jos ennuste esimerkiksi ravinnon riittävyydestä ei vastaakaan 
todellisuutta, tapahtuneet muutokset voivat altistaa häiriöille aikuisiän terveydentilassa. 
Pientä syntymäpainoa täysiaikaisina syntyneillä on yleisesti käytetty vauraassa nyky-
yhteiskunnassa epäedullisen kehityksen osoittajana. Väitöskirjatutkimusten tavoitteena 
oli luonnehtia tarkemmin sekä yhteyksiä syntymäkoon tai lapsuuskasvun ja aikuisiän 
metabolisen oireyhtymän osatekijöiden välillä että näihin yhteyksiin myötä- tai 
vuorovaikuttavia tekijöitä. 
Tutkittavat ja menetelmät. Tutkimuksiin osallistuneet miehet ja naiset kuuluvat kahteen 
vuosina 1924-33 ja 1934-44 Helsingin yliopistollisen sairaalan Naistenklinikalla 
syntyneeseen epidemiologiseen kohorttiin, joista on kerätty syntymän aikaiset tiedot 
kuten paino- ja pituusmitat. Nuoremmasta kohortista on käytettävissä lisäksi 
lapsuudenaikaisia seurantamittauksia.  Vanhemmasta kohortista tutkittiin kliinisesti 500 
henkilöä 65-75 vuoden iässä ja nuoremmasta 2003 henkilöä 56-70 vuoden iässä. 
Kliinisiin tutkimuksiin sisältyi oraalinen sokerirasitus, verenpainemittauksia, kehon 
koostumuksen mittaus bioelektrisellä impedanssilla, kyselyt lääkityksestä ja 
liikuntatottumuksista, ja peroksisomiproliferaattoreilla aktivoituvan reseptori-2 
(PPAR2) geenin Pro12Ala-polymorfismin määritys.  
Tulokset. 65-75 vuotiailla miehillä ja naisilla tunnettu käänteinen yhteys systolisen 
verenpainetason ja syntymäpainon välillä löytyi vain niiltä, joilla oli todettu 
verenpainetauti. Heillä 1 kg korkeampi syntymäpaino vastasi 6.4 mmHg (95% 
luottamusväli: 1.0-11.9) matalampaa systolista verenpainearvoa. Edelleen tämä yhteys 
todettiin vain niillä verenpainetautia sairastavilla, joilla oli PPAR2-geenin vallitseva 
Pro12Pro-muoto (9.3 mmHg/kg, 95% CI: 2.1-16.4). Matala syntymäpaino liittyi 
angiotensiini-1-konvertaasin estäjien ja angiotensiinireseptorin salpaajien runsaampaan 
käyttöön (p=0.03). Myös tällä yhteydellä oli merkittävä interaktio PPAR2-geenin 
 
 
polymorfismin kanssa: pienipainoisina syntyneistä vain Pro12Pro-muodon kantajilla 
nämä lääkkeet olivat useammin käytössä (interaktion p=0.01). 
Säännöllisesti tai kohtalaisella teholla vapaa-ajan liikuntaa harrastavilla vanhemman 
kohortin jäsenillä esiintyi vähemmän sokerinsietokyvyn heikentymistä. Tämä ilmiö oli 
vahvin pienikokoisina syntyneillä. Jos syntymäpaino oli alle 3000 g, heikentyneen 
sokerinsietokyvyn kerroinsuhde (odds ratio, OR) oli 5.2 (95% luottamusväli: 2.1-13) 
harvemmin kuin 3 kertaa viikossa liikkuvilla verrattuna useammin liikkuviin; vain 
kevyttä liikuntaa harrastavilla OR oli 3.5 (1.5 - 8.2) verrattuna teholtaan vähintään 
reipasta kävelyä vastaavaa liikuntaa harrastaviin. 
56-70-vuotiailla 1 kg suurempi syntymäpaino vastasi miehillä 4.1 kg (95% 
luottamusväli: 3.1-5.1) ja naisilla 2.9 kg (2.1-3.6) suurempaa rasvatonta painoa. 
Lapsuuden painoindeksin kehityksen ja aikuisiän kehon koostumuksen välisiä yhteyksiä 
tutkittaessa käytettiin aikuispituudella korjattuja rasvattoman ja rasvamassan indeksejä 
(LMI, rasvaton paino/m2 ja FMI, rasvamassa/m2). Aikuisiän LMI oli sitä suurempi mitä 
korkeampi oli syntymämitoista laskettu painoindeksi (BMI), tai jos kasvoi lapsuusaikana 
nopeasti eli siirtyi BMI-käyrästöllä ylemmäksi minkä tahansa tutkitun neljän 
kasvuvaiheen (0-1, 1-2, 2-7 ja 7-11 v) aikana. Aikuisiän FMI ja kehon rasvaprosentti 
olivat positiivisesti yhteydessä nopeaan BMI-kasvuun vasta toisen ikävuoden jälkeen. 
Päätelmät. Näiden tutkimusten mukaan 65-75 vuotiailla henkilöillä tunnettu yhteys  
syntymäpainon ja systolisen verenpaineen välillä keskittyy verenpainetautiin  jo 
sairastuneisiin. Löydös viittaa siihen, että huonoon sikiöaikaiseen kasvuun liittyvät 
verenpaineen säätelyn patologiset piirteet muuttuvat aikuisiällä itseään ylläpitäviksi ja 
vahvistuvat iän myötä johtaen verenpainetautiin. Pienipainoisina syntyneiden Pro12Pro-
geenimuodon kantajien insuliiniresistenssin vuorovaikutus reniini-angiotensiini-
aldosteroni-systeemin kanssa voi myötävaikuttaa kohonneeseen verenpainetasoon. 
Säännöllinen tai teholtaan vähintään reipasta kävelyä vastaava liikunta suojaa 
sokerinsietokyvyn heikkenemiseltä erityisesti niitä, joilla on suurentunut riski sairastua 
tyypin 2 diabetekseen pienen syntymäpainon takia. 56-70 vuotiailla henkilöillä nopea 
BMI:n kasvu ennen kahden vuoden ikää johti suurempaan aikuisiän rasvattomaan 
painoon ilman rasvamassan kasvua, kun taas nopea BMI-nousu myöhemmän lapsuuden 
aikana johti samanaikaisesta rasvattoman painon lisääntymisestä huolimatta 
suhteellisesti suurempaan rasvamassan lisääntymiseen. Nämä löydökset kuvaavat sitä, 
kuinka geenit ja ympäristö keskinäisine vuorovaikutuksineen, varhainen kasvu ja 
aikuisiän elintavat muuntelevat varhaiskehityksestä juontuvia aikuisiän terveysriskejä. 
Asiasanat: syntymäpaino, verenpaine, kehon koostumus, kohorttitutkimus, elämänkaari, 
epidemiologia, liikunta, insuliiniresistenssi, peroksisomiproliferaattoreilla aktivoituvan 
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The developmental origins of adult health and disease theory has been developed on 
the basis of David Barker’s epidemiological findings in 1980’s and experimental 
studies on animals (1). According to this theory, experiences during critical periods of 
early development may have consequences on health throughout a lifespan. This 
phenomenon is called programming. Changes in body and organ size and structure, 
metabolism, settings of the hormonal axes, and gene expression, created by restricted 
growth or other insults in utero and in infancy, may serve as advantageous adaptations 
aiming at better survival if the restrictive environmental conditions, such as nutrient 
availability, remain meagre in childhood and in later life. In times of plenty, however, 
these adaptations may lead to increased susceptibility to adult diseases.  
Metabolic syndrome is a clustering of cardiometabolic risk factors. It includes major 
health outcomes, e.g. glucose intolerance, elevated blood pressure and abdominal 
obesity (2; 3). These are all linked to low birth weight which, across the whole range 
of normal birth weights in term infants, is a widely used crude indicator of 
unfavourable adjustments to rich societies during fetal life. The epidemiologic 
evidence of these associations is abundant but raises the question of how, and 
through what mechanisms, this programmed propensity to diseases develops and is 
modified during the life course. Experimental studies in animals provide one 
approach to investigate this, but demonstration of these processes in humans is more 
complicated. 
The aim of the present study was to move from previous, mostly descriptive studies 
towards studies focusing on the importance of interactive or additive effects of early 
growth, genetic and socioeconomic factors, and adult lifestyle as the potential 
mechanisms affecting the association between early growth and some components 
of the metabolic syndrome in adult life. This research project is a part of a clinical 
epidemiological study of 15846 subjects, the Helsinki Birth Cohort Study 
(“IDEFIX-study”). Information on childhood growth and development has been 
obtained from birth, child welfare and school health care records. Information on 
adult health, lifestyle and socioeconomic factors has been obtained from national 
registers, census-data, questionnaires and a clinical study of 2503 subjects, who 




2 REVIEW OF THE LITERATURE 
2.1 Developmental origins of adult health and disease 
The hypothesis of the developmental component of subsequent adult diseases was 
brought to broader attention by epidemiological studies by David Barker and 
colleagues in the 1980’s, showing an inverse relationship between birth size and 
disease prevalence or risk factors in later life (4-8). Whereas the interplay between 
genetic and adult lifestyle influences in the development of diseases has long been 
acknowledged, the concept that subtle experiences at the beginning of the lifecycle 
have a substantial effect on later disease risk has opened an entirely new field for 
research during the last two decades.  
The theory was at first criticized: the relationships between poor early growth and 
adult disease were suggested to be explained by confounding factors such as 
selection, recall or publication bias, cohort effect, duration of gestation and 
socioeconomic conditions, or lifestyle throughout lifecycle (9-11). Accumulating 
evidence from several populations worldwide has, however, confirmed the original 
epidemiological findings of the relationship between birth size and major public 
health outcomes, including blood pressure (12), cardiovascular disease (13-18) and 
type 2 diabetes (19; 20), while recent studies of early growth associations have 
expanded research to several other disorders such as osteoporosis (21),  depression 
(22-24) which in itself, interestingly, has been linked with metabolic disturbances 
(25; 26), schizophrenia (27; 28), autoimmune diseases (29), respiratory function (30) 
and cancers (31; 32).  
Since these relationships between birth size and adult disease are independent of 
gestational age, small birth size represents poor fetal growth rather than prematurity. 
However, programming is not confined only to subjects with low birth weight, 
rather the effects operate across the whole range of birth weights. The early 
development of twins differs from that of singletons, and although twin studies are 
utilized in the research on this field, the present review will focus on studies on 
singletons.  
The hypothesis is also supported by data from prospective clinical investigation and 
animal experiments (1; 33). Actually, in several animal species the concept of 
environmental programming has long been accepted: a given genotype can produce 
several phenotypes depending on environmental influences during early growth. For 
example, as early as 1875, the color of a specific butterfly was demonstrated to 
depend on temperature (34); the sex of turtles and crocodilians is determined by 
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temperature during hatching (35; 36). These studies have also highlighted the 
existence of sensitive periods, so called critical windows, during which an influence 
may cause a persistent effect. Timing of these early experiences is crucial also in 
humans: the response to the same environmental factor may differ according to the 
stage of development (35-39). 
Responses to environmental influences during early growth, that determine some of 
the characteristics of adults, have been suggested to be classified according to the 
nature of the response (40). Developmental plasticity should be distinguished from 
developmental disruption, e.g. gross events causing irreversible damage such as 
medication with thalidomide during pregnancy, and from immediately adaptive 
responses promoting immediate survival with long-term consequences such as 
redistribution of blood flow to vital organs under low oxygen conditions (40). 
Obviously, these processes overlap, but developmental plasticity, the range and 
degree of adaptations in physiological homeostatic mechanisms that a fetus or infant 
makes in response to environmental clues during critical windows, aims to guarantee 
the ability to thrive and reproduce successfully in future circumstances that are 
forecasted by the conditions in utero or in early infancy. If this forecast proves to be 
incorrect because of misinterpretation or change in environment, the adaptations 
mismatch with the subsequent reality and may predispose the individual to greater 
health risks, such as disturbances in glucose tolerance, blood pressure regulation and 
the cardiovascular system, that manifest in later life.  
Originally named ‘Fetal origins of adult disease’ with emphasis on thrifty phenotype 
because of intrauterine deprivation, the new terminology reflects the increased 
knowledge on developmental plasticity covering the period from (pre)conception to 
infancy and childhood during which events may induce lifelong consequences on 
the capacity to cope with environment in adult life. In many studies the association 
between birth weight and adult outcome was found or strengthened after adjustment 
for adult size, and Lucas et al. directed attention to the role, whether independent or 
interactive, of change in size between birth and adulthood (41). The framework is 
further expanding towards genetic effects, epigenetic silencing of gene expression 
via DNA methylation, and intergenerational effects as underlying and modifying 
factors behind the recognized associations (42-46). All these factors and their 
interactions, that establish resilience or susceptibility to later environmental stressors 
including lifestyle, can be viewed from a lifecourse concept (Figure 1, reprinted with 
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Figure 1. The lifecourse concept for fetal, childhood and adult effects on health in adulthood. The effects of an individuals
family history, (epi)genome and susceptibility factors throughout life may interact, e.g. vulnerability to an adverse lifestyle
may vary by a given genetic polymorphism or by adverse experiences during growth. The latter may be indicated as e.g. 
small birth size or slow growth rate during childhood. Reprinted with permission from Kajantie 2003 (42).
 
 15
2.2 Characteristics of growth in early life  
2.2.1 Periods of growth 
Human growth consists of three partly overlapping periods: 1) the rapid fetal growth 
period that continues into infancy; 2) the childhood growth; and 3) the growth spurt 
in puberty (48). Growth during the early fetal period consists mainly of increase in 
cell numbers, hyperplacia, while increase in cell size, hypertrophy, gradually takes 
over. Apart from cell divisions and hypertrophy, cell differentiation, migration, 
interaction with other cells and organs, and apoptosis are essential in completing the 
growth process. After the growth period, a majority of cell types undergo constant 
renewal but the ability to grow is limited and occurs mostly by means of increase in 
cell size. 
The role of growth-regulating hormones and other growth factors varies according 
to the growth phase. Among other factors, insulin and insulin-like growth factors are 
significantly involved in fetal and infant growth whereas growth during childhood is 
largely dependent on growth hormone and thyroxine (49). In puberty the important 
influence of growth hormone is joined by sex hormones. The nuances of growth 
regulation remain partly unresolved. 
Most of the growth, relatively, occurs in the fetal period, during which the highest 
growth rate is approximately tenfold compared to the growth rate in mid-childhood 
(Figure 2) (47). Linear growth, e.g. rate of length gain, is greatest at approximately 
20 week of gestation, and rate of weight gain at 34 weeks. During rapid growth the 
fetus is most vulnerable to environmental influences.  
These characteristics of growth, i.e. the restricted duration of the growth phase combined 
with the highest growth rates in utero, illustrate the large potential of lifelong 
consequences if growth is disturbed during early life. The timing and nature of the 
influence, e.g. lack of nutrients, determines the pattern of the response, the complexity of 
which may further vary by other factors such as genotype and gender (50; 51). 
2.2.2 Determinants of birth size 
Small birth size is, because of its availability, widely used in studies assessing the 
effects of early growth on later health, although it is an imprecise and crude marker 
of an adverse intrauterine environment. Naturally, some small babies have not 
experienced any growth restriction but are genetically small, representing the lower 
tail of the normal birth weight distribution. Correspondingly, a part of growth-
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restricted babies fall into the category of normal weight babies because of their 
greater genetic growth potential. Nevertheless, up to 45% of variance in birth weight 
has been estimated to be due to effects of uterine environment, with fetal genome 
explaining 10-15%, maternal fixed features including genes explaining 25%, and 
maternal factors varying from pregnancy to pregnancy explaining 20% of the 
variance. 
 




















Figure 2. Growth velocity throughout the human growth period. The scale of the Y axis  is 
the same for both parts of the figure, illustrating the high growth rate during the fetal
period compared with postnatal life. Reprinted with permission from Kajantie 2003 (42).
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A number of endocrine, nutritional, socioeconomic, behavioral (e.g. maternal 
smoking) and other factors have an impact on birth size. Most of these, such as the 
effect of paternal size and the sex of the fetus, can be traced to the genome of the 
fetus, whereas others such as parity and maternal size represent the degree of 
maternal constraint. In general, the genome of the fetus determines fetal growth until 
restricted by maternal and uteroplacental conditions, i.e. maternal constraint. These 
growth-limiting processes act e.g. by limiting nutrient supply or by re-setting the 
metabolic-hormonal axes that regulate growth (52). Physiological maternal 
constraint acts in all pregnancies and is greater by younger maternal age, smaller 
maternal size and primi- or multiparity (53-55). Pathological processes, such as 
placental defects, may further enhance the constraint. The mechanisms of maternal 
constraint are poorly researched but probably involve the response of the 
uteroplacental vessels to pregnancy, imprinting of genes, transgenerational effects 
and maternal diet (1; 52; 56). In addition, birth size is obviously largely dependent 
on the duration of gestation. 
2.2.3 Rate of postnatal growth in relation to later health 
Genetically set growth trajectory determines growth potential (57). Periods of 
impaired growth, due to environmental reasons, are followed by accelerated growth 
until the original inherited growth path is reached. This is evident in infants born 
small for gestational age: 90% of them show postnatal catch-up growth in weight, 
height and BMI, defined as centile crossing on standard growth charts (58-60). This 
is usually evident by 6 months of age. Regression to the mean explains only a small 
degree of the catch-up and catch-down phenomena. Of all infants, approximately 
one-quarter show catch-up growth, while half follow the same weight or length 
centile position from birth (60). However, not all growth deficits due to 
environmental exposures, such as poor nutrition or maternal pregnancy smoking, are 
compensated during later growth (61; 62). 
Catch-up growth -hypothesis suggests that the crucial feature of the development of 
long-term consequences of restricted fetal growth is the early postnatal growth rate 
(41; 63). Traditionally slow postnatal growth of infants born small has been 
interpreted as detrimental in the short-term context of failure to thrive, with 
emphasis on malnutrition or food deprivation and cognitive development in 
childhood. There is little evidence on associations between childhood growth rate 
and health in adulthood, but recent findings in the Helsinki cohort showed that slow 
gain in weight or BMI between birth and 2 years of age was associated with 
coronary heart disease and its risk factors including type 2 diabetes (64; 65). 
However, the potential benefits of growth promotion in infancy or early childhood 
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have been contradicted: in younger populations, some of those born preterm or small 
for gestational age, rapid postnatal growth has been linked with risk factors of 
cardiovascular disease (66-70). In adults, a rapid gain in weight or BMI during later 
childhood, after impaired fetal and infancy growth, has increased the risk of type 2 
diabetes and coronary heart disease (64; 65; 71). Despite the discrepancies of its 
timing during childhood, postnatal high rates of growth in subjects born small also 
seem to be crucial for blood pressure levels (72-74). Some studies suggest that the 
type of growth, whether linear or ponderal, is essential in the development of 
growth-rate related adult health risk factors and outcomes (73; 75; 76).  
To sum up, from the life-course perspective, a period of poor growth in utero or 
early infancy followed by rapid growth may increase susceptibility to metabolic 
disorders most. On the other hand, a specific postnatal growth pattern might reverse 
the effects of fetal programming. The potential public health impact of this approach 
is considerable because growth in infancy and childhood is more amenable to 
interventions than that of a fetus. Nevertheless, longitudinal studies are needed to 
explore the long-term outcomes of different growth rates at several periods of 
growth before any nutritional or other interventions to regulate growth can be 
recommended. Unfortunately this type of confirmation takes decades; meanwhile 
cross-sectional studies with data on childhood growth and adult outcomes may offer 
important information. However, the interpretations of growth data are further 
complicated because there is no single recommended statistical method to measure 
and analyze growth patterns. For example, different definitions of slow gain in 
weight or BMI in childhood have been shown to identify different populations with 
different profiles (77).  
2.3 Mechanisms of programming 
Hales and Barker referred to individuals with bodies and metabolism adapted to a 
low level of nutrition as having a “thrifty phenotype” (78). Nutritional signals are, 
indeed, likely to have a key role in initiating programming (1; 79). This is 
purposeful also from an evolutionary framework: in a deprived environment 
reproduction of individuals adapted to low caloric intake is presumably more 
successful, promoting species survival through transient changes in the environment 
(33; 52). However, if the signals during fetal life about expected environment are 
erroneous or inaccurate because of maternal disease, placental dysfunction or change 
in environmental conditions after birth, such as nutritional improvement in 
developing societies, the fetus is predisposed to an increased disease risk in later 
life. In rich modern societies the discrepancy between prenatal nutritional supply, 
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limited by physiological maternal constraint, and postnatal abundant nourishment is 
great even without any adverse experiences in utero. 
Numerous animal experiments support the importance of nutrient supply in 
programming (1; 80; 81). The fetal programming of e.g. hypertension has been 
modeled in several species mostly by subjecting dams to undernutrition during 
pregnancy (80). Offspring of these pregnancies develop hypertension and other 
features linked to insulin resistance (80). In humans the best evidence of in utero 
undernutrition in the development of adult glucose intolerance, cardiovascular 
disease and hypertension comes from studies on men and women exposed to 
wartime famine during the Dutch Hunger Winter while in utero (37; 38; 82; 83).  On 
the other hand, these studies have also shown that restricted maternal nutrition is not 
synonymous with reduced offspring birth size; the latter may be related with an 
adult outcome while the former is not (84; 85). However, in contrast to the Dutch 
studies, maternal exposure to extreme undernutrition during the siege of Leningrad 
could not be associated with offspring outcome (86). Since the duration of the Dutch 
famine was relatively short and clear-cut, 5 months, while in Leningrad exposure to 
food shortage may have continued into infancy and even later childhood, the 
different level of postnatal nutrition and growth might provide one explanation. 
Whatever the initiating event, nutritional or other, it may trigger several possible 
mechanisms that eventually lead to increased susceptibility to adult diseases. The 
fetus may respond to the trigger by sustained metabolic, neuroendocrine or structural 
changes. The degree and variety of these changes and vulnerability or resilience 
depend on its developmental stage and genome. Figure 3 presents a framework of 
suggested mechanisms for the biological basis of the associations between fetal 
experiences and adult health outcomes (87).  
Among the mechanisms, alterations in the regulation of the hypothalamic-pituitary-
adrenal (HPA)-axis are likely to play an essential role (88-93). Permanently changed 
set-points of the HPA-axis together with changes in the sympathoadrenal system, 
which also mediates the stress response, may affect metabolism and the vasculature 
in a way that predisposes to e.g. insulin resistance and hypertension (51; 94; 95). 
There is evidence of exaggerated BP or cortisol response to stress in offspring that is 
related to maternal nutrition (92; 96). Several pathways to a single outcome are 
possible: essential hypertension has also been proposed to be a consequence of a 
reduced nephron number which increases susceptibility to progressive glomerular 
injury and thus progressively rising blood pressure (97; 98). In line with this 
hypothesis, nephron numbers in neonates and in adults have been shown to be 
related positively to birth weight across the range of birth weights (99; 100). Other 
suggested mechanisms in the development of hypertension include the renin-
angiotensin system which plays a role in both nephrogenesis and the development of 
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hypertension (81; 101), altered growth hormone secretion (102) and changes in 
vascular structure or function (103-106). 
 
Figure 3. The concept of developmental origin of adult health and disease:
potential internal and external mechanisms operating during the growth period. 
These mechanisms describe how the adversities during critical periods of early life 
are retained into adult life and translated into diseases. Modified from Räikkönen
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Programming may also include changes in body composition such as reduced 
muscle mass and altered muscle function (107-110). Small birth size for gestational 
age, the indicator of fetal adaptations, seems to be primarily attributable to reduced 
lean body mass (111) and this deficit tracks through childhood (112) and 
adolescence (113) into adulthood (114-117). Catch-up growth after fetal or infancy 
gowth retardation has been suggested to favour fat accumulation, specifically 
abdominal fat, at the cost of lean mass, and this tendency may persist into adulthood 
(60; 118-120). These changes in body composition may play a role in the 
development of insulin resistance which is the major metabolic disturbance behind 
the metabolic syndrome and related traits; actually the dynamic phase of catch-up 
growth has also been presented as a state of insulin resistance (121). Other suggested 
mechanisms include epigenetic modification of genes such as changes in expression 
of imprinted genes that regulate placental nutrient transfer capacity (122) and altered 
hormone sensitivity (123).  
2.4 Developmental origin of components of the metabolic 
syndrome 
2.4.1 Early growth and the adult metabolic syndrome 
The metabolic syndrome is a clustering of risk factors for cardiovascular diseases 
and type 2 diabetes. The definition of this syndrome varies, but the central features 
are abdominal obesity and insulin resistance (3; 124; 125). Which comes first and 
whether there is a single underlying pathogenetic mechanism is still under debate. 
Other metabolic abnormalities include varying degrees of glucose intolerance, 
dyslipidaemia and hypertension. Table 1 presents the current definition in Europid 
subjects by the International Diabetes Federation (2; 3). 
Studies on developmental origins of adult disease have strongly linked small birth 
size or early growth with the individual components of the metabolic syndrome and 
related diseases (5; 16; 126-129). Studies using an accepted definition of the 
metabolic syndrome rather than its components have been less consistent in linking 
small birth size with the syndrome. Obviously the different definitions in these 
studies partly explain this. Middle-aged Finnish men in the lowest third of birth 
weight or ponderal index were roughly two times more likely to have the metabolic 
syndrome than men in the highest tertile (130). The risk related to low birth weight 
was comparable to that in young adults in Netherlands (131). In contrast, in another 
Dutch study the prevalence of the metabolic syndrome was not greater after prenatal 
exposure to famine, nor was it associated with a reduced birth weight in that study 
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(132), in young adults in Amsterdam (133) or in middle-aged men and women in 
Newcastle (134).  
 
Table 1. Definition of the metabolic syndrome by the International Diabetes 
Federation 2005 (2; 3). 
Central obesity 
 Waist circumference (values are ethnicity specific) 
   94 cm in Europid men 
   80 cm in Europid women 
Plus any two: 
 Raised triglyceride level 
   1.7 mmol/l 
  or specific treatment for this lipid abnormality 
 Reduced HDL cholesterol   
  <1.03 mmol/l in men 
  <1.29 mmol/l in women 
  or specific treatment for this lipid abnormality 
 Raised blood pressure  
  systolic  130 mmHg 
  diastolic  85 mmHg 
  or treatment of previously diagnosed hypertension 
 Raised fasting plasma glucose 
   5.6 mmol/l 
  or previously diagnosed type 2 diabetes 
 
Studies assessing the relationship between childhood obesity or growth and adult 
metabolic syndrome are difficult to compare because of their different approaches 
with various ages at which the children or adults were assessed and various 
definitions of obesity, mostly based on body mass index (BMI). The limitations of 
BMI as an index of obesity must also be recognized since it denotes both lean and 
fat mass. In a study with cross-sectional data on both childhood and adulthood, 
children with their BMI in the highest quartile at the age of 7 years had an increased 
risk of  the metabolic syndrome at the age of 36-46 years (135). However, in another  
study the sensitivity of childhood obesity in predicting the adult metabolic syndrome 
was low, with 37% for the 85th and 15% for the 95th childhood BMI percentile as the 
cut-off value, and only half of the obese children had the metabolic syndrome as 
adults (136). To improve the precision to identify children who eventually develop 
metabolic complications, other markers in addition to obesity should be included in 
possible screening programs. 
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A few studies have assessed the persistence or change in relative size between two 
points in time in relation to the presence of the adult metabolic syndrome. Catch-up 
growth between birth and adulthood in men was predictive of the syndrome in two 
studies (134; 137). An upward shift in age-specific BMI percentile from childhood 
to adulthood increased the risk of the metabolic syndrome considerably (138). The 
role of the timing of the shift was not assessed although the study included children 
with a wide age range (5-19 years with a mean of 12.8 years). However, in another 
study childhood obesity by the age of 7 years, that tracked into adulthood, was a 
greater risk factor for the metabolic syndrome than obesity that developed during 
later life (139). In contrast, in a study assessing the various cardiometabolic risk 
factor levels of the metabolic syndrome, rather than the presence of a clinic entity, 
these risk factor levels in obese subjects did not vary by the age of obesity onset (8 
years, 12-17 years, 18 years) (140). The relationship between childhood obesity 
and the risk factor levels resulted from the persistence of the obesity status from 
childhood to adulthood (140).  
Timing of the increase or decrease in growth rate as evidenced by centile crossing, 
irrespective of the absolute level of fatness, may be critical for whether the change is 
deleterious or beneficial for later health. This is exemplified by several studies. The 
age of obesity onset has been suggested to be crucial for later obesity, its persistence 
and metabolic complications (141; 142); patterns of childhood growth that are 
related to adult obesity may differ from those related to the development of 
metabolic adversities (143); the hypothesis that metabolically healthy obese subjects 
differ from obese subjects with the metabolic syndrome in terms of childhood 
growth rate changes and their timing receives some support from one study on 
children (144). Thus the need for longitudinal studies with data on BMI or 
preferably more specific measurements of adiposity at several points during 
childhood is obvious.  
A recent study illustrated how different adult outcomes were preceded by different 
pathways of growth. When adults with and without the metabolic syndrome were 
compared, the onset of a difference in BMI was shown to occur at age 8 years in 
boys and 13 years in girls whereas the growth curves diverged at ages 3 years in 
boys and 9 years in girls in those who did and did not become obese (BMI30) (Sun 
2008). Remarkably, despite the difference, the BMI values of most children at risk 
of metabolic adversities later in life did not exceed the recommended arbitrary 





2.4.2 Birth size and blood pressure level 
The inverse relationship between weight at birth and systolic blood pressure (BP) 
level has been extensively studied across several ethnic groups and in age groups 
ranging from infancy to old age. These studies have been reviewed by Law et al. 
(145) and Huxley et al. (146), summarizing data from 28 to 80 studies with 15000 to 
444000 subjects, respectively. Table 2 presents data on studies of the relationship 
between birth weight and systolic BP in subjects aged 50 years or more. In general, 
the first two reviews estimated that a 1 kg higher birth weight is associated with a 2 
mmHg lower systolic BP.  
This conclusion, however, was challenged by a third review by Huxley et al. 
claiming that the inverse association between birth weight and current BP may 
chiefly reflect the impact of random error, reporting bias, and the inappropriate 
adjustment for potential confounders such as current weight (11); the latter may 
reflect the importance of postnatal growth (41). The proposal of a statistical artefact 
was supported by Tu et al. with their simplified approach which showed that if both 
birth weight and adult BP are positively correlated with current weight while not 
correlated with each other, then adjustment for current weight can induce a negative 
correlation between birth weight and adult BP (147). Studies and commentaries 
thereafter have addressed these questions. Publication bias has been estimated to 
reduce the magnitude of the inverse association between birth weight and systolic 
BP but not to explain it (148). The suggestion by Huxley et al. that larger studies 
reporting weaker associations are more reliable has been criticized because these 
studies have included self-report of recalled blood pressure and subjects on 
antihypertensive drug therapy (149), the number of whom is higher by lower birth 
weight (150; 151). A study with comprehensive follow-up data from early 
pregnancy up to early thirties was able to take into account a large scale of potential 
confounders including current size; the inverse association was found whether or not 
adjusted for current BMI (152). That study and others have emphasized the role of 
gestational age (152; 153). 
To overcome the limitations of previous reviews, the most recent meta-analysis used 
a standardized meta-regression method on both published and unpublished raw data 
from 20 cohort studies in six Nordic countries including data from the Helsinki Birth 
Cohort Study (50). That study showed, again, an inverse association between birth 
weight and systolic BP. As expected, it was strengthened after adjustment for 
current BMI, and attenuated but still significant after adjustment for gestational age. 
There was an apparent sex-difference: the association was linear among males but in 
females only up to the birth weight of 4 kg after which it was inverted. Non-linearity 


























































































































































































































































































































































































































































































































































































































































































































































































































































The magnitude of the association in the Nordic study was estimated to be -0.75 
mmHg/kg in men aged 18-24 years with a change of -0.26 mmHg/kg for each 10-year 
increase in age. The corresponding estimates for women with a birth weight below 4 
kg were -1.74 (reference age 25-34 years) and -0.53 mmHg/kg. Calculated from these, 
in men and women aged over 64 years the regression coefficients would be -2.05 and -
3.86, respectively. This amplification over the lifecourse has previously been proposed 
by Law et al. (154) but it could not be confirmed in a longitudinal study with repeated 
measurements in middle age (155). There may be a cohort effect or a wider 
distribution of systolic BP in the older populations (50; 153); nevertheless, the effects 
of age and year of birth are difficult to disentangle (50).  
While the association between birth weight and systolic BP level has been shown to 
be robust, the small effect of birth weight on BP seems to contradict with the 
substantial effect on the prevalence of hypertension (150). The mechanisms for this 
and several other aspects deserve attention. Only two other studies have compared 
the associations of birth weight with systolic BP between hypertensive and non-
hypertensive subjects (155; 156). Studies of a possible common genetic factor 
behind both fetal growth and later risk for high BP or the effects of antihypertensive 
medication are rare (157). Moreover, most studies have based the evaluations of the 
association on an office BP measurement in a single occasion. Discussion on 
statistical issues continues to highlight the complexity of research on developmental 
origins of adult health (158; 159). 
PPAR 2 gene polymorphism  
Developmental plasticity may be modified by genes. Environmental factors may 
produce different outcomes depending on the genes of the individual. Certain 
genotypes may be protective whereas other genotypes may make an individual more 
vulnerable to adverse early experiences. Since insulin resistance is closely related to 
many diseases linked to poor early growth, polymorphisms of genes involved in 
glucose metabolism and adipogenesis are obvious candidates for studies on the 
interactions between genes and early environment. 
The peroxisome proliferator-activated receptor  (PPAR) is a nuclear hormone 
receptor that has a crucial role in regulation of target genes involved in adipogenesis, 
lipid and glucose metabolism (160; 161). PPAR can bind a variety of endogenic 
compounds and is the main target of the insulin-sensitizing drugs, thiazolidinediones, 
which are used in the treatment of type 2 diabetes. The isoform PPAR2 is 
expressed predominantly in adipose tissue. The most prevalent known variant of the 
PPAR2-gene is Pro12Ala polymorphism, in which alanine substitutes proline (C-
toG nucleotide change) in codon 12 in the PPAR2-specific exon B, resulting in 




frequency of the Ala variant is approximately 0.12, indicating a carrier prevalence of 
the polymorphism in this ethnic group of approximately 25% (162; 163). In our 
study population the frequency of Ala-allele was 0.173 (164). 
Two meta-analyses have confirmed that the Ala-allele is associated with a 
significantly reduced individual and population-attributable risk for type 2 diabetes 
(165; 166). In this respect the PPAR gene is one of the most important genes 
identified to date at the population level: if everybody carried the Ala-allele, 
according to the most optimistic estimate, the global prevalence of type 2 diabetes 
would be 25% lower (166). The risk-reduction is probably mediated mainly by 
greater insulin sensitivity (160; 163; 167), in which the adipose tissue has an active 
role (160; 167).  
However, the environment may considerably modify the effects of the Pro12Ala 
polymorphism on insulin resistance which may partly explain the inconsistencies in 
different studies. A meta-analysis in nondiabetic subjects found that only in the 
obese subgroup (BMI > 30 kg/m2) the surrogate markers of insulin resistance were 
significantly higher in the Pro12Pro carriers (168). Obesity and ethnic background 
interact with the polymorphism also on the prevalence of type 2 diabetes (169). 
Other evidence on interactions affecting insulin sensitivity in relation to Pro12Ala 
polymorphism include studies on the effects of other genes (170-172), nutrients 
(173), exercise (173) and development in utero (164; 174). Overall, it has been 
suggested that the carriers of the Ala-allele are protected against adverse 
environmental influences, such as a high-fat diet and a lack of exercise, and thus are 
less prone to develop diabetes and cardiovascular disease (175). 
Since insulin resistance is closely linked not only with type 2 diabetes but also with 
hypertension, it is not surprising that Pro12Ala polymorphism has also been studied 
in association with blood pressure and hypertension. These studies show even more 
variation. In Caucasian subjects the Ala-allele has been found to be associated with 
higher systolic and diastolic BP in family members of type 2 diabetic subjects (176), 
with lower diastolic BP in diabetic men (177) and higher diastolic BP in obese 
diabetic subjects (178), or no relationship has been found between polymorphism 
and systolic or diastolic BP levels or hypertension in nondiabetic or diabetic subjects 
(179; 180). However, subjects with Pro12Pro genotype and normal plasma 
homocysteine values have had a higher risk for hypertension (181). Taken together, 
similarly as with insulin resistance, environmental factors are likely to modify the 
effects of Pro12Ala polymorphism on blood pressure. There have been no studies on 
what kind of role early growth might play in this respect. 
 
 
2.4.3 Birth size, glucose intolerance and physical activity 
While several studies have suggested an inverse linear relationship between birth 
weight and the risk of type 2 diabetes (5; 19; 20; 127), a recent meta-analysis 
showed that it is U-shaped, high birth weight being associated with increased risk 
of type 2 diabetes to a similar extent as low birth weight (182). Fetal 
macrosomia, resulting from exposure to high glucose levels because of maternal 
diabetes, may contribute to this association since the offsping of diabetic mothers 
have been shown to have an increased risk of type 2 diabetes in later life (183). 
The higher end of the birth weight distribution may thus become more important 
in predicting the disease risk in industrialized countries with high prevalence of 
overweight women who have an increased risk of maternal diabetes.  
Physical exercise has a favourable effect on several cardiometabolic risk factors: 
it decreases blood glucose levels, improves insulin sensitivity and serum lipid 
profiles, decreases body fat mass and reduces blood pressure level (184). 
Therefore, it is not surprising that the risk of type 2 diabetes can be reduced by 
lifestyle intervention including increasing physical activity (185). Those subjects 
had an increased risk for type 2 diabetes because of their impaired glucose 
tolerance status. It remains to be shown whether subjects with another risk factor, 
small birth size, might as well be protected from the development of type 2 
diabetes by physical activity. Furthermore, physical fitness or activity in itself 
may be related to birth size (130; 186), possibly because of changes in e.g. 
cardiopulmonary or muscle capacity (1). 
2.4.4 Birth size, early growth and adult body composition 
Human body composition can be presented at several levels ranging from 
chemical elements to molecular, cellular and tissue level. A two-compartment 
model that divides the body into fat and fat-free masses is classically used in 
studies on physical fitness, nutritional status and obesity. The term lean mass is 
often used synonymously to fat-free mass.  
Estimates of total body fat and lean mass can be assessed by a variety of 
methods. These include anthropometry, such as measuring the thickness of 
subcutaneous fat by calipers in multiple regions of the body, underwater 
weighing which is based on different buoyancy of body fat and lean tissue, 
scanning of the body by dual energy X-ray absorptiometry (DXA), magnetic 
resonance imaging (MRI), computed tomography (CT), and bioelectric 
impedance analysis which is presented below. All these methods have their 




are expensive and not easily available, and the latter exposes the subject to a 
considerable level of X-rays especially in repeated examinations.  
The largest constituent of fat-free mass is water. Because only water in the body 
conducts electrical current, the resistance of an electrical current through the body 
can be used to estimate total body water and thus fat-free mass. This is called 
bioimpedance analysis. Early analyzers could not distinguish intracellular water 
from extracellular water and the measurement was restricted to, for example, the 
upper body. Technological improvements, such as the use of a spectrum of 
electrical flows and 4 pairs of electrodes to measure the resistance of each limb and 
trunk separately, have improved the accuracy of this method (187). 
Adult obesity and low birth weight are both risk factors for the metabolic 
syndrome. Paradoxically, adult obesity is predicted by high birth weight (143; 
188-192). However, since obesity has mostly been assessed by BMI which 
denotes lean mass as well as fat mass, methods that distinguish these components 
may illuminate this paradox. Another reason to analyze body composition in 
relation to early growth is the evidence of certain growth patterns as predictors of 
adult cardiovascular disease and type 2 diabetes or their risk factors (64; 65; 71; 
129; 193); effects of early growth on body composition may play a role in the 
development of these diseases. Insulin resistance, the central component of the 
metabolic syndrome, is in itself linked to low birth weight or thinness at birth 
(19; 75; 194-196). This association is amplified in subjects whose small size or 
thinness at birth were followed by later catch-up growth in BMI, even in the 
absence of actual overweight or development of obesity (19; 171; 197-201). 
Studies on body composition have shown that infants born small for gestational 
age seem to have reduced lean mass, rather than fat mass, throughout childhood 
and adulthood (111-117). Since the main component of lean mass, muscle mass, 
is important for glucose homeostasis regulation, the relative deficiency of lean 
mass may predispose to insulin resistance.  
Fat distribution pattern has been suggested to be programmed during fetal life 
(202-205). While these results seem to support the fetal origin of the metabolic 
syndrome, with a large waist circumference as a key feature, many of these 
studies have assessed abdominal obesity by the waist-hip ratio. The relationship 
of low birth weight with higher waist-hip ratio has been suggested to represent a 
reduced hip size rather than abdominal deposition of fat (204). Furthermore, 
anthropometric measurements do not distinguish subcutaneous and intra-
abdominal fat, the latter of which is the metabolically active component.   
Studies with an accurate method to measure abdominal fat are rare (206-208). In 
a twin study utilising magnetic resonance imaging birth weight was inversely 
 
 30
associated with abdominal visceral and subcutaneous fat (207). One study 
suggests an early interplay between insulin resistance and abdominal fat 
deposition (208). In that study children born small for gestational age, compared 
with children born appropriate for gestational age, shifted from insulin sensitivity 
to insulin resistance between ages 2 and 4 years after largely completed catch-up 
growth by 2 years of age, and the development of insulin resistance was 
accompanied by increased gain of fat and deposition of fat more centrally 
according to a DXA scan despite similar gain in BMI.   
Few studies with various methods have assessed the effects of childhood growth 
on body components in later life. A study in 9 year old boys showed that rapid 
weight gain in infancy was associated with height or lean mass whereas weight 
gain between 1 and 4 years of age predicted both lean mass and fatness, and 
rapid weight gain thereafter only fatness (209). Another study on 4 year old 
children showed that at age 2 years body composition of children born small for 
gestational age, despite largely completed catch-up growth, did not differ from 
that of children born appropriate for gestational age (208). In contrast, between 
ages 2 and 4 years they gained more fat, specifically abdominal fat, and less lean 
mass while changes in overall weight, height and BMI were similar. In 
Guatemalan young adults accelerated increase in height between birth and 2 
years of age was related to higher fat percentage (210). Three studies in adults 
have suggested that high rates of weight or BMI gain in infancy and childhood 
are associated with an increase in both adult lean mass and adiposity (211-213). 
However, in the young Indian adults the gain in BMI up to 8 years of age was 
more strongly associated with adult lean mass than with adiposity while the 
strength of the association with adult adiposity increased steeply between 2 and 8 
years and was sustained up to 14 years of age (212). 
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3 AIMS OF THE STUDY 
The overall aim was to explore the associations of early growth with components 
of the adult metabolic syndrome. Another focus was on factors that may underlie 
or modify these associations: a well-characterized gene polymorphism, physical 
activity and adult body composition, all of which are known to affect insulin 
sensitivity. 
The specific objectives were: 
1. To assess the effects of birth size on blood pressure levels in men and 
women with and without established hypertension at 65-75 years of age 
(Study I). 
2. To assess whether peroxisome proliferator-activated receptor  2 
(PPAR2) gene polymorphism interacts with the relationship between 
birth size and adult blood pressure level or with the relationship between 
birth size and the use of any class of antihypertensive medication in 
hypertensive 65-75 year old men and women (Study II).  
3. To examine whether habitual regular exercise has a protective effect 
against glucose intolerance in 65-75 year old subjects with a recognized 
risk factor for glucose intolerance, i.e. small body size at birth (Study 
III). 
4. To examine how body size at birth is related to adult body composition 
at 56-70 years of age, and how this is related to grip strength (Study IV). 
5. To examine how change in body mass index throughout childhood is 
related to adult lean and fat mass at 56-70 years of age (Study V). 
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4 SUBJECTS AND METHODS 
4.1 Study populations 
Participants of these studies belong to clinically examined subsets of two birth 
cohorts with data on size at birth and during childhood. These original cohorts 
comprise 7086 and 8760 subjects. They were born as singletons in 1924-33 and 
1934-44 in the Helsinki University Central Hospital, went to school in Helsinki 
and were alive and residing in Finland in the year 1971. Members of the younger 
cohort attended child welfare clinics. Of the older cohort, 500 subjects 
participated in a clinical study at the age of 65 to 75 years between December 
1998 and March 2000. Of the younger cohort, 2003 subjects participated in the 
clinical study at the age of 56 to 70 years between August 2001 and March 2004. 
Data on the cohorts has been collected from three types of records preserved in 
hospital archives or in the Helsinki City Archives. First, standardised birth 
records include birth weight (rounded to the nearest 10 g) and length (to the 
nearest 0.5 cm), father’s occupation, and mother’s age, height, weight (recorded 
before delivery), parity and date of her last menstrual period. Second, school 
health records on children who attended the schools in Helsinki include serial 
height and weight measurements recorded from 7 to 15 years of age. Third, child 
welfare records with data on weight and height in infancy and at intervals 
thereafter are available for the younger cohort. On average, men and women 
from the clinically examined subset of the younger cohort have a median of 10 
measurements of weight and height between birth and the age of 2 years and 8 
measurements between 2 and 11 years. 
Each individual, identified by linking these records, was matched with the 
population register in order to find the personal identification number which has 
been allocated to each member of the Finnish population since 1971. This unique 
number was then used to trace the cohort members who were still alive and 
living in Finland. Members of the older cohort (n=5210) were sent a postal 
questionnaire in the year 1998 and members of the younger cohort (n=10530) in 
the year 2001. Participants of the clinical studies were selected among those who 
responded and gave us permission to take further contacts. 
Studies I-III. A total of 674 people from the older cohort still living in the 
Helsinki area were invited to attend a clinical study and 500 of them agreed to do 
so. Characteristics and variables of interest of these subjects are presented in 
Table 3. Of them, only subjects with medication for hypertension were included 
in Study II. 
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Studies IV-V. To obtain a sample size in excess of 2000 people, 2902 randomly 
selected people from the younger cohort were invited to attend a clinical study. 
Of them, 2003 participated and were included in Study IV. 1917 men and women 
had data on their body composition and were included in Study V. 
Characteristics of the participants are presented in Table 4. 
4.2 Clinical examination 
Subjects attended the clinic in the morning between 8.00 and 10.00, after an 
overnight fast, to have blood tests. Body weight was measured to the nearest 0.1 
kg in light clothing without shoes, and height was measured to the nearest 
millimetre. Body mass index was calculated as kg/m2. Waist circumference was 
measured with a soft tape midway between the lowest ribs and the iliac crest and 
that of hip at the level of great trochanters.  
The Ethics Committee of the National Public Health Institute had approved the 
study protocol of studies I-III. Studies IV-V were approved by the Ethics 
Committee of Epidemiology and Public Health of the Hospital District of 
Helsinki and Uusimaa. Written informed consent was obtained from each 
participant.  
Studies I-III (older cohort). Blood pressure was measured after a 10-min rest 
from the right arm in the sitting position using a standard mercury 
sphygmomanometer (Omron Matsutaka Europe, Hoofdorp, the Netherlands) and 
the mean of two successive readings was recorded. Subjects on medication for 
hypertension were asked not to take their medication on the morning of clinic 
attendance.  
A 24-hour ambulatory blood pressure monitoring with a portable device 
(SpaceLabs Medical 90207, SpaceLabs Inc, Redmond, Washington) was 
performed on a subsample of 169 subjects. Because of lack of sufficient 
equipment to offer ambulatory monitoring to all subjects, we invited subjects to 
participate as equipment became available. Those currently on drug therapy 
resumed it before monitoring commenced. The recorder was attached before 
midday to the non-dominant arm. Blood pressure was measured at 20-minute 
intervals from 6:00 AM to 9.00 PM and at 60-minute intervals from 9:00 PM to 
6:00 AM. The ambulatory pressure was averaged over 24 hours. 
In Study I subjects were defined as hypertensive if they reported that they had 
been previously diagnosed by a physician as having hypertension. 175/213 
(82%) of them were currently on antihypertensive medication. In Study II, 
definition of hypertension was based on the use of antihypertensive medication 
(Table 1). Medication was divided into four classes: diuretics, beta-adrenergic 
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receptor blockers, angiotensin converting enzyme inhibitors/angiotensin-receptor 
blockers (ACEI/ARB) and calcium channel antagonists. 
Percentage body fat was determined by a handheld bioelectric impedance 
analyser (Omron Body Logic Body Fat Analyzer; Omron Healthcare). 
Data on exercise habits were derived from self-administered questionnaires. 
Frequent exercise was defined as 3 or more times of regular leisure time exercise 
per week. Intensity of exercise was grouped into two categories: 1. light (such as 
walking) or 2. moderate (such as brisk walking) or strenuous (such as jogging). 
Yearly energy expenditure (kcal) on physical activity was estimated by a 
validated exercise questionnaire (KIHD 12-month leisure time physical acitivity 
history, (214)). In the exercise history, the subjects were asked to report the 
frequency, average duration and intensity class of each leisure time physical 
activity during the previous 12 months. An exercise-related yearly energy 
expenditure score (kcal) was then calculated by multiplying the duration of each 
activity by the caloric coefficient of the specific activity and intensity class.  
An oral glucose tolerance test (OGTT) was started in the morning, after an 
overnight fast, with the ingestion of 75 g of glucose. Plasma glucose 
concentrations were measured by a hexokinase method from samples drawn at 0, 
30 and 120 min.  The results were interpreted according to the WHO 1999 
criteria (215). Insulin concentrations were determined by a two-site 
immunoradiometric assay. The homeostatic model assessment index of basal 
insulin resistance was calculated as the product of fasting glucose and insulin 
(mU/l) divided by 22.5. 
The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-
2 (PPAR2) gene was determined for 476 of the 500 subjects by the polymerase 
chain reaction single-strand conformation polymorphism method. The genotypes 
were encoded as 0 = Pro12Pro and 1 = Pro12Ala and Ala12Ala.  
 
 35
Table 3. Characteristics of the 65 to 75 year old participants and selected variables of interest 
in Studies I-III. Mean value (SD) unless otherwise stated. 
Birth and adult characteristics   
 Men, n=186 Women, n=314 
   
Birth weight, g 3445 (458) 3296 (464) 
Length at birth, cm 50.2 (1.7) 49.7 (1.8) 
Ponderal index, kg/m3 27.1 (2.4) 26.7 (2.3) 
Age at clinical examination, years  69.4 (2.9)  69.7 (2.7) 
Adult body mass index, kg/m2 27.3 (3.9) 27.8 (4.6) 
 Study I 
 Inclusion criteria: Attendance to the clinical study, n=500 
 Normotensive (57%) Hypertensive (43%) 
 Men, n=111 Women, n=176 Men, n=75 Women, n=138 
Adult body size     
 Height, cm 174.4 ((5.5) 160.5 (5.1) 174.4 (5.9) 160.2 (6.1) 
 Waist circumference, cm 99.6 (10.0) 88.5 (10.8)** 102.5 (11.4) 93.4 (11.7)** 
 Body fat, % 30.0 % (4.3) 40.4 (4.7) 30.8 (4.4) 41.7 (4.2) 
Blood pressures, mmHg     
 Clinic systolic 151 (20)** 154 (22)** 168 (21)** 166 (20)** 
 Clinic diastolic 87 (11)** 85 (9)** 96 (10)** 91 (10)** 
 24-hour ambulatory systolica 130 (14)* 129 (13)* 138 (17)* 135 (14)* 
 24-hour ambulatory diastolica 77 (9)* 74 (7) 82 (8)* 76 (8) 
 Study II 
 Inclusion criteria: Use of antihypertensive medication n=208  
PPAR-2 gene polymorphismb Pro12Pro, n=141 Pro12Ala/Ala12Ala, n=67 
Blood pressures, mmHg   
 Clinic systolic 165 (21) 166 (21) 
 Clinic diastolic 91 (11) 91 (10) 
 24-hour ambulatory systolica 135 (14) 132 (18) 
 24-hour ambulatory diastolica 77 (9) 76 (8) 
Fasting plasma insulin, pmol/lc 86 (1.3)** 63 (1.8)** 
HOMA indexd 3.3 (2.0)** 2.3 (2.0)** 
Antihypertensive drugs, n (%)e  
 Diuretics 68 (33%) 
 -adrenergic receptor blockers 119 (57%) 
 ACEI/ARB f 64 (31%) 
 Calcium channel antagonists 57 (27%) 
 Study III 
 Inclusion criteria: Attendance to the clinical study, n=500 
Glucose tolerance status, n (%)  
 Normal glucose tolerance 257 (51%) 
 Impaired glucose tolerance 141 (28%) 
 Diabetes 102 (20%) 
Frequency of exercise, n (%)  
 <3 times per week 268 (54%) 
 >3 times per week 217 (43%) 
Intensity of exercise, n (%)  
 Light 262 (52%) 
 Moderateg or strenuous 233 (47%) 
*p<0.05; **p < 0.001 in Study I for difference between normotensive and hypertensive subjects; in Study 
II for difference between different PPAR-2 gene polymorphism carriers. 
a Performed on a subsample of 169 (72 hypertensive) subjects. b Peroxisome proliferator-activated 
receptor-2. c Geometric means. d Homeostatic model assessment insulin resistance index. e 82 subjects 
received more than one medication. f Angiotensin converting enzyme inhibitors and angiotensin-receptor 
blockers. g Comparable to brisk walking.
 
 
Studies IV-V (younger cohort). Estimates of total lean and fat mass were measured 
by a bioelectrical impedance analysis (BIA) using the InBody 3.0 eight-polar tactile 
electrode system (Biospace Co., Ltd, Seoul, Korea). This method was chosen 
because of its practicality in large epidemiological studies with limited time for 
examination of each subject (216; 217). The outputs of the analyser are based on 
segmental multifrequency analysis of each limb and trunk, and on measured values 
only. Empirical data, such as sex and age or population-specific algorithms, are not 
used (216-218). The method has been shown to have a reasonable accuracy in 
several ethnic groups including Europid men and women with a wide age range 
(219). Resistance was measured at frequencies of 5, 50, 250 and 500 kHz with the 
subject standing barefoot in light clothing on four foot electrodes on the platform of 
the analyser and gripping the two palm and thumb electrodes. The estimates of body 
components were derived from calculations using the manufacturer’s software.  
Isometric grip strength of the dominating hand was tested by a Newtest Grip Force 
dynamometer (Newtest Oy, Oulu, Finland). The maximum value of three squeezes 
was used in analyses. The dynamometer was not available, or the test was not 
performed due to hand pain, for 104 subjects. 
Smoking habits and frequency of leisure-time exercise were derived from self-
administered questionnaires. A subject was defined as a smoker if he/she smoked 
one or more cigarettes per day, and as physically active if he/she exercised regularly 
and at least moderately three or more times per day. Moderate exercise was defined 
as comparable to brisk walking. Occupation-based social class was derived from the 
census data in 1980. Social class in childhood (upper middle, lower middle or 
manual worker) was based on the father’s occupation recorded in birth, child welfare 
clinic and school records, of which the occupation indicating the highest social class 







Table 4a. Childhood characteristics of the 56 to 70 year old men and women in 
Studies IV-V. Mean value (SD) unless otherwise stated. 
 Study IV (n=2003) Study V (n=1917)* 
     
Characteristics at 









Weight     
 Birth, g 3476 (501) 3353 (465) 3472 (502) 3349 (465) 
 1 year, kg    10.5 (1.0) 9.9 (1.0) 
 2 years, kg   12.4 (1.1)  11.9 (1.1) 
 7 years, kg   22.6 (2.6 22.2 (2.9) 
 11 years, kg   33.9 (4.6) 34.4 (5.7) 
Length/Height, cm     
 Birth 50.7 (2.1) 50.0 (1.8) 50.7 (2.1)  50.0 (1.8)  
 1 year   76.6 (2.5) 74.9 (2.5) 
 2 years   86.8 (3.0) 85.5 (3.0)   
 7 years   121.0 (4.8) 120.0 (4.6) 
 11 years   141.7 (5.9) 141.6 (6.6) 
BMI, kg/m2     
 Birth   13.5 (1.2)  13.4 (1.2)  
 1 year   17.8 (1.3) 17.6 (1.4) 
 2 years   16.6 (1.2)  16.4 (1.2)  
 7 years   15.5 (1.1) 15.5 (1.3) 
 11 years   16.8 (1.5) 17.1 (1.9) 
Ponderal index at birth, 
kg/m3 
26.6 (2.3) 26.7 (2.2)   
Gestational age, days 280 (11) 280 (11) 280 (11) 280 (11) 
Maternal characteristics     
 Age, years 28.8 (5.5) 28.7 (5.5)   
 Height, cm 159.6 (6.0) 159.5 (5.6)   
 Body mass index, 
kg/m2 
26.5 (3.0) 26.5 (2.8)   
Social class in 
childhood a 
    
 Upper middle, % 19 15 19 15 
 Lower middle, % 24 22 24 22 
 Manual worker, % 57 63 57 63 
*885 men and 1032 women with bioimpedance analysis. At least 832 observations in 
men and 976 in women were available for each variable. 
a The highest social class indicated by father’s occupation, derived from birth, child 





Table 4b. Adult characteristics of the 56 to 70 year old men and women in 
Studies IV-V. Mean value (SD) unless otherwise stated. 
 Study IV (n=2003) Study V (n=1917)* 
     








 Age, years  61.5 (2.8) 61.5 (3.0) 61.5 (2.8) 61.5 (3.0) 
 Height, cm 176.8 (6.0) 163.2 (5.7) 176.8 (6.0) 163.2 (5.7) 
 Weight, kg 86.2 (14.3) 73.8 (13.8) 86 (14) 74 (14) 
 BMI, kg/m2 27.5 (4.2) 27.7 (5.0) 27.5 (4.0) 27.7 (5.0) 
 Waist circumference, cm 100.2 (1.1) b 90.2 (1.1) b 100.8 (11.3) 91.0 (12.9) 
 Hip circumference, cm 101.3 (1.1) b 103.9 (1.1) b   
 Smokers, % 29 21 29 20 
 Physically active c, % 46 44 46 44 
Adult body composition     
 Lean mass, kg 65.0 (7.9) 47.8 (5.7) 65.0 (7.8) 47.8 (5.7) 
 Lean mass index, kg/m2   20.7 (1.8) 17.9 (1.7) 
 Fat mass, kg 19.6 (1.5)b 24.0 (1.5) b 20.9 (8.1) 25.7 (9.6) 
 Fat mass index, kg/m2   6.7 (2.6) 9.7 (3.7) 
 Percent body fat 23.8 (6.0) 33.9 (6.9) 23.7 (5.9) 33.9 (6.9) 
Adult muscle strength     
 Grip strength, kg 40.2 (9.4) 22.9 (6.3) 40.4 (9.5) 22.8 (6.5) 
Social class in adulthood d     
 Higher official, % 40 25 40% 25% 
 Lower official, % 25 59 25% 59% 
 Manual worker, % 29 13 29% 12% 
 Self-employed, % 5 3 5% 3% 
*885 men and 1032 women with bioimpedance analysis. At least 832 observations in men and 
976 in women were available for each variable. 
b Geometric means. 
c Those exercising at al level comparable to brisk walking three or more times per week. 
d Based on occupation, derived from the census data in 1980. 
4.3 Statistical analyses 
Studies I-III.. The blood pressure data was analysed by using multiple linear 
regression (p- values refer to continuous variables) and tabulation of means. In 
Study II, multiple logistic regression was used to analyze the proportion of subjects 
receiving antihypertensive medication and in Study III the relations between birth 
size, measures of exercise habits and glucose tolerance status. Variables that had 
skewed distributions (scores of yearly caloric expenditure on exercise, plasma 
glucose and insulin concentrations and homeostatic model assessment) were log-
transformed for analyses.  
Studies IV-V. All analyses were performed separately for each sex. One extremely 
obese man with a BMI of 68 kg/m2 was excluded from the analyses.  
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In Study IV, linear regression with continuous variables was used to explore the 
relation of birth size with adult body size and composition and grip strength. 
Variables with skewed distribution (waist and hip circumference and fat mass) were 
log transformed to obtain a more symmetrical distribution. Three models were used: 
an unadjusted model, a model adjusted for age and adult height, and a model 
adjusted for age and adult BMI. To assess the effect of potential confounders we 
performed simultaneous regressions using as independent variables birth weight, 
adult height or BMI, and variables that in univariate analyses had been related to 
adult body composition.  Subgroup analyses and tests of interaction were conducted 
to assess whether the effects of birth weight varied by adult body size and 
composition. 
In Study V, each measurement of BMI in infancy and childhood for each individual 
was converted to a sex-specific z-score (SD score). The z-score is the number of 
standard deviations by which an observation differs from the mean for the whole 
study group. Because the children were not measured on their exact birthdays we 
obtained a z-score at each birthday by interpolation if measurements had been made 
within 2 years of that age. Piecewise linear interpolation was used on the z-scale to 
help accommodate non-linearity in raw BMI with age. The cross-sectional 
correlations between BMI z-scores in childhood and adult outcome variables were 
analyzed. Because the number of measurements was smaller at ages 3-5 years than 
at other ages (866-1318 versus 1833) and for consistency with previous studies on 
Helsinki birth cohort, data at birth and ages 1, 2, 7 and 11 years were chosen to be 
analyzed further. Periods between these ages are long enough to enable our aim to 
analyse the effects of a change from a growth path predicted by earlier growth. 
Postnatal change in BMI between chosen ages was calculated by saving the 
residuals from linear regression models of BMI z-scores at each successive age 
versus BMI z-score at all earlier ages. These residuals, referred as conditional z-
scores, are mutually uncorrelated, and enable the effects of change in BMI during 
different growth periods to be distinguished (220). The effects on adult body 
composition of BMI at birth and change in BMI after birth, during the four periods 
of growth, were examined by multivariate linear regression. Analyses were adjusted 
for age. Because body size indicates the absolute amounts of both lean and fat mass, 
in this study we used height-normalized indices as has been recommended  (lean and 
fat mass were divided by height squared, LMI and FMI, respectively) (221; 222). 
Further adjustments with life style factors were performed. Significance was defined 





5.1 Birth size, adult body size and blood pressure in 65-75 year old 
men and women with and without established hypertension 
Birth and adult characteristics of the 500 study subjects are presented in Table 3. 
43% of all subjects had hypertension diagnosed by a physician and 82% of them 
were currently on antihypertensive medication. 
Size at birth and at the age of 65-75 years 
The hypertensive subjects had shorter body length at birth (p=0.02) and lower 
placental weight (p=0.04) than those without hypertension. These associations were 
little changed by an adjustment for the duration of gestation (length, p=0.01; 
placental weight, p=0.04) or by the exclusion of people born before term.  
Size at birth  and adult blood pressure 
Systolic BP was lower by greater birth weight and birth length. It was unrelated to 
the duration of gestation. These associations related to small body size at birth were 
confined to people with hypertension (Table 5, p=0.06 for interaction between birth 
weight and hypertension; p=0.05 for interaction between birth length and 
hypertension). Among people with hypertension a 1 kg increase in birth weight was 
associated with a 6.4 mmHg (95% CI, 1.0 to 11.9) decrease in systolic BP. The 
corresponding figure for nonhypertensive people was -1.2 (95% CI, -6.7 to 4.3), 
whereas for the total study sample it was 3.5 (95% CI, -0.6 to 7.6). Trends in men 
and women were similar. If hypertension was defined as systolic BP >160 mmHg, 
recorded at the clinic, rather than as a self-reported diagnosis, the findings were 
similar. This definition categorized 228 (46%) people as hypertensive. When we 
used lower values of systolic BP, 150 or 140 mmHg, the majority of the people were 
categorized as hypertensive. Nevertheless, the interaction between birth weight and 
hypertension remained. There were similar but not statistically significant trends 
with regard to diastolic BP.  
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Table 5. Systolic blood pressure recorded at the clinic in subjects with and without 









Birth weight, g    
 2500 156 (10) 182 (15) 172 
 3000 150 (42) 164 (31) 156 
 3500 155 (139) 168 (98) 160 
 4000 152 (74) 164 (56) 157 
 >4000 152 (21) 163 (13) 156 
 p for trend* 0.63 0.02 0.10 
Birth length, cm    
 48 153 (37) 170 (42) 162 
 49 152 (60) 168 (36) 158 
 50 156 (87) 165 (66) 160 
 51 150 (55) 167 (42) 157 
 >51 152 (47) 164 (26) 156 
 p for trend* 0.67 0.01 0.03 
*Adjusted for age, gender, and body mass index. 
 
 
Table 6. Mean ambulatory 24-hour systolic blood pressure in subjects with and without 









Birth weight, g    
 2500 127 (2) 145 (4) 139 
 3000 129 (16) 145 (12) 136 
 3500 130 (44) 134 (33) 131 
 4000 130 (25) 134 (20) 132 
 >4000 129 (9) 120 (2) 127 
  p for trend* 0.51 0.01 0.10 
Birth length, cm    
 48 126 (11) 143 (15) 136 
 49 130 (23) 137 (13) 133 
 50 132 (23) 135 (24) 133 
 51 129 (21) 132 (12) 130 
 >51 130 (18) 125 (6) 129 
 p for trend* 0.81 0.03 0.05 
*Adjusted for age, gender, and body mass index.  
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The same associations were examined in the 169 people who had ambulatory BP 
measurements. The 24-hour mean BPs were 133/79 mmHg in men and 132/75 
mmHg in women. The correlation between ambulatory measurements and those 
made at the clinic were 0.60 for systolic BP and 0.63 for diastolic pressure. Table 6 
shows that the trends with systolic BP over 24 hours were similar to those for 
pressure recorded at the clinic (interaction between birth weight and hypertension, 
p=0.02; interaction between birth length and hypertension, p=0.07). Among people 
with hypertension a 1 kg increase in birth weight was associated with a 9.3 mmHg 
(95 CI, 2.1 to 16.5) decrease in systolic BP. The corresponding figure for 
nonhypertensive subjects was -1.9 (95% CI, -0.7 to 8.5), whereas for hypertensive 
and nonhypertensive subjects combined, it was 3.9 (95% CI, -0.7 to 8.5). There were 
no significant trends with diastolic pressure. 
 
Table 7. Systolic blood pressure recorded at the clinic in subjects with and without 
established hypertension according to body mass index, waist circumference and 
body fat percentage. Values are mean (n). 
 







Body mass index, kg/m2    
 24 144 (63) 166 (32) 151 
 26 152 (68) 167 (39) 157 
 28 155 (53) 163 (46) 159 
 30 151 (45) 172 (32) 160 
 >30 164 (57) 168 (64) 166 
 p for trend* <0.001 0.38 <0.001 
Waist circumference    
 80 147 (45) 167 (19) 153 
 90 148 (73) 165 (52) 155 
 100 153 (95) 168 (67) 159 
 110 158 (55) 168 (49) 163 
 >110 171 (18) 166 (26) 168 
 p for trend* <0.001 0.66 <0.001 
Body fat, %    
 30 146 (58) 167 (34) 154 
 35 149 (60) 169 (38) 157 
 40 154 (69) 168 (42) 159 
 45 154 (71) 165 (61) 159 
 >45 168 (27) 165 (33) 167 
 p for trend* <0.001 0.89 <0.001 
*Adjusted for age and gender 
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Adult body size and blood pressure  
High adult body mass index was associated with higher systolic BP. When we 
examined this trend separately among nonhypertensive and hypertensive subjects, 
we found that it was present only among nonhypertensive subjects. Table 7 shows 
that among people with hypertension systolic blood pressure was unrelated to body 
mass index, waist circumference, or percentage of body fat (p<0.001 for interaction 
between body mass index and hypertension). There were similar trends with regard 
to diastolic pressure (p=0.01 for interaction). 
5.2 Birth size, PPAR2 gene polymorphism and adult blood 
pressure in subjects on antihypertensive medication 
Among the 208 men and women on antihypertensive medication, a 1 kg increase in 
birth weight was associated with a 6.9 mmHg (95% CI: 0.9-12.9) decrease in 
systolic BP and a 1 cm increase in birth length was associated with a 2.2 mmHg 
(95% CI: 0.7-3.7) decrease in systolic BP. Adjustment for duration of gestation had 
little effect.  
The mean systolic BP varied according to the type of antihypertensive medication 
being used. It was 162 mmHg among people taking diuretics, 165 mmHg among 
those taking beta-blockers, 168 mmHg among those taking calcium channel-
blocking agents, and 171 mmHg among those taking ACEI/ARBs. 82 subjects were 
taking more than one medication. 
A total of 141 (68%) of the 208 subjects had the Pro12Pro polymorphism while 63 
(30%) had the Pro12Ala and 4 (2%) had the Ala12Ala polymorphism of the 
PPAR2 gene.  Mean birth weight did not differ between the carriers of different 
polymorphisms. 
Adult BP level according to birth size and PPAR2 gene polymorphism 
The greater the birth weight or length, the lower was the adult systolic BP measured 
at the clinic or during the ambulatory 24 h recording. Table 8 presents that this effect 
was confined to people with the Pro12Pro polymorphism, among whom a 1 kg 
increase in birth weight was associated with a 9.3 mmHg decrease (95% CI: 2.1-
16.4, p=0.01) in clinic systolic BP and a 1 cm increase in birth length was associated 
with a 3.3 mmHg decrease (95% CI: 1.4-5.1, p=0.001) in clinic systolic BP. The 
interaction between the effects of birth length and the polymorphism was 
statistically significant (p=0.05). Exclusion of those subjects who had not reported a 
diagnosis of hypertension did not attenuate the associations. Findings in the two 
sexes were similar. There were no interactive effects on ambulatory or diastolic BP. 
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Birth size, PPAR2 gene polymorphism and use of different types of antihypertensive 
medication  
Low birth weight was related to the use of ACEI/ARB but not to the use of the other 
medications as presented in Table 9. This relationship remained significant when 
only those 126 subjects receiving monotherapy, 16 of them on ACEI/ARB, were 
included in analyses. In a simultaneous regression, use of ACEI/ARB was predicted 
by low birth weight (p=0.04), high systolic pressure (p=0.02), younger age (p=0.02) 
and by the use of anti-diabetic medication (n=21, p=0.006). The patient’s PPAR2 
genotype, sex or BMI had no influence on the use of ACEI/ARB. 
Table 10 presents the percentage of hypertensive people taking ACEI/ARB 
according to their birth weight and birth length and the PPAR2 gene 
polymorphisms. In people with the Pro12Pro polymorphism, low birth weight and 
short body length at birth were both associated with the use of ACEI/ARB. This 
finding was detected also in those on monotherapy (15 of them on ACEI/ARB). 
These are statistically significant interactions between birth size and polymorphisms 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 10. Percentage of men and women with hypertension who were taking 
angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers 
according to peroxisome proliferator-activated receptor-2 (PPAR 2) gene 
polymorphism and body size at birth. 
 PPAR2 polymorphism 
 Pro12Pro Pro12Ala/Ala12Ala 
Characteristic % r/n % r/n 
Birth weight (g)     
 <3000 64 18/28 14 2/14 
 >3000 26 29/113 28 15/53 
 All 33 47/141 25 17/67 
 p-value 0.003 0.32 
 Adjusted p-value* <0.001 0.25 
 p-value for interaction 0.01 
Length at birth (cm)     
 <49 44 24/54 17 4/23 
 >49 26 23/87 28 12/43 
 All  33 47/141 24 16/66 
 p-value 0.01 0.18 
 Adjusted p-value* 0.009 0.16 
 p-value for interaction 0.02 
r/n are numbers of subjects taking angiotensin-converting enzyme inhibitors or 
angiotensin-receptor blockers and numbers of subjects with hypertension. One 
subject had unknown length at birth.  




5.3 Birth size, regular physical activity and glucose intolerance 
Table 3 presents the glucose tolerance status and exercise habits of the study 
subjects. 173 subjects scored their leisure time physical activity as moderate and 60 
as strenuous; in most analyses these were combined. 
Table 11 shows the prevalence rates and odds ratios (ORs) for type 2 diabetes and 
impaired glucose tolerance (IGT) according to weekly exercise frequency and 
intensity, as well as yearly energy expenditure on exercise in relation to birth size. 
Frequent and moderately intense exercise were both associated with lower rates of 
glucose intolerance. This effect was strongest in subjects whose birth weight was 
<3000g. There was a significant interaction between exercise frequency and birth 
weight (p=0.003). The birth weight-related positive effects of exercise did not differ 
within different adult BMI groups or between the sexes. Adjustment for age, 
parental history of type 2 diabetes or concomitant diseases did not change the 
findings. Strenuous exercise did not give more protection against glucose 
intolerance compared to moderate exercise. 
Thinness at birth, assessed using ponderal index at birth, showed a similar 
statistically significant relationship between small birth size and all three 
measurements of exercise (Table 11). Yearly energy expenditure on exercise 
interacted significantly with ponderal index. 
In males, exercise frequency correlated inversely with birth weight (p=0.009, 
adjusted for age and BMI) and ponderal index (p=0.033). The latter correlated 
inversely also with exercise intensity (p=0.030) and yearly energy expenditure on 































































































































































































































































































































































































































































































































































































































5.4 Birth size, change in BMI in childhood and adult body 
composition 
Table 4 shows the characteristics of the study subjects in childhood and adulthood. 
Correlations between key anthropometric variables at birth and in adulthood are 
presented in Table 12. 
Childhood BMI in relation to current growth charts 
According to current World Health Organization (WHO) growth charts (223), the 
mean BMI at birth corresponded to the 52nd and 50th percentile in boys and in girls, 
respectively. 2.7% and 3.7% of newborn boys and girls, respectively, were at or 
above the 95th percentile. At the age 2 of years, 8.7% or 7.9% of boys and 12.3% or 
11.3% of girls were at or above the 95th percentile according to WHO or at or above 
the BMI cutoff point corresponding to a BMI of 25 at age 18 according to the 
International Obesity Task Force (IOTF) (224), respectively. Only the latter growth 
charts include the age of 11 years. At this age no one was above the BMI 
corresponding BMI of 30, the limit for obesity, and 0.9% of boys and 3.8% of girls 
were overweight (at or above the BMI corresponding to a BMI of 25 at the age of 18 
years by the IOTF). 
During the first two years after birth 43% of boys and 45% girls followed the same 
BMI percentile (gain or loss in BMI z-score <=0.67 SD), whereas 27% and 28% of 
boys and girls, respectively, crossed upward. Between ages 2 and 11 years 49% of 
boys and 46% of girls remained at the same BMI percentile, whereas 24% of them 
had crossed upward. 
Size at birth and in adult life 
Birth weight was positively related to adult BMI, but in women this relationship was 
dependent on adult height (Tables 12 and 13). High birth weight predicted a larger 
hip circumference. The positive association of birth weight with waist circumference 
in men disappeared after adjustment for BMI. 
Weight at birth and adult body composition 
Birth weight correlated strongly with adult lean mass in the unadjusted model and in 
the models adjusted either for age and adult height or age and adult BMI (Table 13). 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































age, gestational age, smoking status, physical activity, and social class in childhood 
and adulthood.  
Fat mass and distribution were not consistently related to birth weight. In men high 
birth weight was related to greater fat mass in unadjusted and height-adjusted 
models but unrelated in a BMI-adjusted model; in women there was no significant 
association between birth weight and fat mass. On the other hand, higher fat 
percentage was predicted in the BMI-adjusted model by lower birth weight.  
The association of birth weight with adult body fat percentage in men depended on 
the level of adult BMI (p for interaction birth weight*adult BMI = 0.002) as shown 
in Table 14. Low birth weight was associated with higher body fat percentage only 
in those with a BMI below 30 kg/m2. In men with a BMI over 30 kg/m2 this trend 
seemed to reverse although this did not reach statistical significance. In women the 
interaction between the effects of birth weight and adult BMI on fat percentage was 
not statistically significant (p = 0.56).  
 
Table 14. Adult body fat percentage (n) according to birth weight in different 
categories of adult body mass index (BMI). 
 Adult BMI (kg/m2) 
 <25 kg/m2 25-30 kg/m2 >30 kg/m2 
Men    
Birth weight    
3000 g 19.4 (41) 24.5 (78) 29.5 (29) 
3000-3500 g 18.1 (101) 23.6 (187) 30.5 (74) 
>3500 g 18.0 (100) 23.2 (213) 30.9 (103) 




(-2.19 to -0.16) 
-1.11 
(-1.85 to -0.36) 
0.89 
(-0.32 to 2.09) 
p for trend 0.042 0.012 0.15 
Women    
Birth weight    
3000 g 27.9 (88) 34.8 (98) 43.0 (62) 
3000-3500 g 27.4 (135) 34.1 (173) 41.2 (121) 
>3500 g 26.6 (124) 33.9 (163) 40.9 (110) 




(-2.38 to -0.13) 
-0.61 
(-1.33 to 0.12) 
-0.90 
(-2.0 to 0.21) 
p for trend 0.030 0.10 0.11 
p = 0.002 for interaction between birth weight and categories of BMI in men; p = 
0.56 in women 
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Change in BMI in infancy and childhood in relation to adult body composition 
Figure 4 shows the relationship between childhood BMI and adult outcome 
variables. In both sexes, a higher adult BMI was predicted by higher BMI 
throughout childhood. Similarly, a higher BMI during childhood predicted a higher 
lean mass index (LMI) in adulthood.  
Because we aimed to examine to what extent a change in BMI in different periods of 
growth was related to adult body components, next we used conditional measures 
which are mutually uncorrelated by construction. This measure tells whether change 
in childhood BMI between two ages is greater or less than would be expected from 
BMIs at earlier ages, rapid gain meaning crossing from an original growth percentile 
in this population to a higher one. Table 15 shows that, independently of each other, 
a higher BMI at birth and a higher gain in BMI during each period analyzed were 
associated with a higher LMI in adulthood. For example, a 1 SD increase in 
conditional BMI between birth and 1 year of age was related to a 0.17 kg/m2 and 
0.22 kg/m2 increase in adult LMI in men and women, respectively.  
Figure 4 shows that adult fat mass index (FMI) was predicted by a higher BMI later 
in childhood. Accordingly, a higher FMI was predicted by a higher gain in BMI 
between 2 and 7, and 7 and 11 years, but not by BMI at birth or change in BMI 
between birth and 2 years (Table 15). Body fat percentage and waist circumference 
showed similar associations. 
Adult body composition in relation to age, lifestyle and maternal characteristics  
In Study IV, higher age was associated with lower adult lean mass in men (p<0.001) 
but not in women. Physical activity or smoking were not associated with lean body 
mass. Lower age (p=0.016 in men and p=0.007 in women), frequent physical 
activity (p<0.001), higher social class in childhood (p<0.001 in men and p=0.031 in 
women) and in adulthood (p<0.001) were associated with a lower body fat 
percentage. We calculated maternal BMI from height and weight measured before 
delivery. Lower maternal height (p<0.001), lower maternal BMI (p=0.008 in men 
and p=0.002 in women) and lower maternal age at delivery (p=0.024 in men) were 
associated with a lower lean mass of the adult offspring. In women, taller maternal 
height (p=0.001) and higher maternal BMI (p<0.001) predicted a lower body fat 
percentage. Gestational age at birth and mother’s parity (firstborn or other) had no 
effect on outcomes. 
In Study V, a simultaneous regression with age, physical activity level, smoking 
status and social class in childhood and adulthood showed that LMI was lower by 












































































































































































Table 15a. Body mass, lean mass and fat mass indices at the age of 56-70 years 
according to tertiles of body mass index (BMI) at birth and change in BMI up to the age 
of 11 years in men. Linear regression coefficients indicate how many units each 
dependent variable changes by a difference of 1 SD in BMI at birth or a 1 SD increase in 
conditional BMI between selected ages.  
MEN BMI 
(kg/m2) 
Lean mass index 
(kg/m2) 
Fat mass index 
(kg/m2) 
BMI at birth (n=875)   
1 lowest  27.2 20.5 6.6 
2 middle 27.4 20.6 6.7 
3 highest 27.9 21.0 6.8 
Regression coefficient  
(95% CI) 
0.44 
(0.18 to 0.70) 
0.24 
(0.13 to 0.36) 
0.212 
(0.04 to 0.382) 
p for linear trend 1 0.001 <0.0001 0.022 
    
BMI at 1 year adjusted for BMI at birth (n=875)  
1 lowest  27.3 20.6 6.7 
2 middle 27.4 20.7 6.6 
3 highest 27.8 20.9 6.8 
Regression coefficient  
(95% CI) 
0.23 
(-0.03 to 0.49) 
0.17 
(0.06 to 0.29) 
0.06 
(-0.12 to 0.23) 
p for linear trend 1 0.08 0.003 0.5 
    
BMI at 2 years adjusted for BMI at 1 year (n=875)  
1 lowest  27.1 20.4 6.6 
2 middle 27.8 20.8 6.9 
3 highest 27.7 20.9 6.7 
Regression coefficient  
(95% CI) 
0.22 
(-0.04 to 0.48) 
0.21 
(0.09 to 0.32) 
0.01 
(-0.16 to 0.19) 
p for linear trend 1 0.1 0.001 0.9 
    
BMI at 7 years adjusted for BMI at 2 years (n=842)  
1 lowest  26.6 20.2 6.4 
2 middle 27.3 20.7 6.6 
3 highest 28.5 21.3 7.1 
Regression coefficient  
(95% CI) 
0.87 
(0.61 to 1.13) 
0.44 
(0.32 to 0.55) 
0.44 
(0.26 to 0.61) 
p for linear trend 1 <0.0001 <0.0001 <0.0001 
    
BMI at 11 years adjusted for BMI at 7 y (n=811)  
1 lowest  26.7 20.4 6.3 
2 middle 27.4 20.7 6.7 
3 highest 28.3 21.1 7.2 
Regression coefficient  
(95% CI) 
0.73 
(0.47 to 1.00) 
0.32 
(0.20 to 0.43) 
0.41 
(0.24 to 0.59) 
p for linear trend 1 <0.0001 <0.0001 <0.0001 
1 Adjusted for age.   
2 When geometric means are used (skewness corrected), the regression coefficient is 1.9% (-0.6% 
to 4.4%, p=0.1).  
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Table 15b. Body mass, lean mass and fat mass indices at the age of 56-70 years 
according to tertiles of body mass index (BMI) at birth and change in BMI up to the age 
of 11 years in women. Linear regression coefficients indicate how many units each 
dependent variable changes by a difference of 1 SD in BMI at birth or a 1 SD increase in 
conditional BMI between selected ages.  
WOMEN BMI  
(kg/m2) 
Lean mass index 
(kg/m2) 
Fat mass index 
(kg/m2) 
BMI at birth (n=1022)   
1 lowest  27.6 17.7 9.6 
2 middle 27.1 17.9 9.5 
3 highest 28.4 18.2 9.9 
Regression coefficient  
(95% CI) 
0.31 
(-0.003 to 0.62) 
0.20 
(0.10 to 0.30) 
0.11 
(-0.12 to 0.34) 
p for linear trend 1 0.05 0.0001 0.4 
    
BMI at 1 year adjusted for BMI at birth (n=1022)  
1 lowest  27.4 17.7 9.6 
2 middle 27.5 17.9 9.5 
3 highest 28.2 18.2 9.9 
Regression coefficient  
(95% CI) 
0.38 
(0.07 to 0.69) 
0.22 
(0.12 to 0.32) 
0.17 
(-0.06 to 0.40) 
p for linear trend 1 0.02 <0.0001 0.2 
    
BMI at 2 years adjusted for BMI at 1 year (n=1022)  
1 lowest  27.3 17.7 9.4 
2 middle 27.6 17.9 9.5 
3 highest 28.3 18.2 10.0 
Regression coefficient  
(95% CI) 
0.38 
(0.08 to 0.69) 
0.20 
(0.10 to 0.30) 
0.19 
(-0.04 to 0.42) 
p for linear trend 1 0.02 0.0001 0.1 
    
BMI at 7 years adjusted for BMI at 2 years (n=972)  
1 lowest  26.8 17.5 9.2 
2 middle 27.4 17.9 9.3 




(0.89 to 1.52) 
0.46 
(0.36 to 0.57) 
0.74 
(0.51 to 0.98) 
p for linear trend 1 <0.0001 <0.0001 <0.0001 
    
BMI at 11 years adjusted for BMI at 7 y (n=936)  
1 lowest  26.5 17.6 8.9 
2 middle 27.6 17.9 9.5 




(0.62 to 1.24) 
0.26 
(0.16 to 0.36) 
0.66 
(0.43 to 0.89) 
p for linear trend 1 <0.0001 <0.0001 <0.0001 
1 Adjusted for age. 
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women LMI was lower by higher social class in adulthood (p=0.003). Higher FMI 
was predicted by physical inactivity (p<0.0001), by lower social class in adulthood 
(p=0.03 in men and 0.0005 in women), in men by non-smoking (p=0.02) and lower 
social class in childhood (p=0.0003), and in women by higher age (p=0.004). 
Neither in Study IV nor in Study V did the adjustment for these variables change the 
relationships between birth size or childhood growth and adult body composition. 
Grip strength in relation to adult characteristics and size at birth  
Among the 56 to 70 year old subjects measurements related to lean mass were 
positively associated with grip strength.  For example, a one kilogram increase in 
lean mass corresponded in men to a 0.38 kg (95 % CI: 0.31, 0.46, p<0.001) and in 
women to a 0.29 kg (95 % CI: 0.22, 0.35, p<0.001) increase in grip strength.  Fat 
percentage was inversely associated with grip strength in men (0.23 kg per unit, 95 
% CI:  0.33,  0.12, p < 0.001). Other factors related to lower grip strength were 
higher age and smoking.  A one year increase in age corresponded to a 0.7 kg (95 % 
CI: 0.5, 1.0) and a 0.5 kg (95 % CI: 0.4, 0.6) decrease in grip strength in men and 
women, respectively, and male and female smokers had 1.6 kg (95 % CI: 0.2, 3.1) 
and 1.5 kg (95 % CI: 0.4, 2.6) lower grip strength than non-smokers, respectively. 
Grip strength was related to birth weight.  A one kilogram increase in birth weight 
corresponded to a 1.8 kg increase in grip strength in both men and women (95 % CI: 
0.6, 3.1 in men and 0.9, 2.6 in women, Table 13).  This association disappeared after 
adjustment for height (Table 11) and in men also after adjustment for the amount of 
lean mass (0.03 kg, 95% CI:  1.2, 1.2). In women this association diminished after 




6.1 Birth size and adult health 
6.1.1 Birth size and adult blood pressure level 
 Small body size at birth was associated with higher systolic BP in men and women 
aged 65-75 years. In the total sample, the increase in systolic BP associated with a 1 
kg decrease in birth weight was small, 3.5 mmHg, which is similar to what has been 
shown previously (50; 146). 
A novel finding, however, was that in these elderly people this association was only 
present among those who had hypertension. Among them the inverse association 
between birth weight and systolic BP was more remarkable: a 1 kg increase in birth 
weight was associated with a 6.4 mmHg decrease in systolic BP recorded at the 
clinic. Consistent with this finding, two other studies have reported missing or 
weaker inverse association between birth weight and systolic BP among people 
without antihypertensive treatment compared to people on treatment or the 
combined group of those who had never taken antihypertensive drugs and those who 
had (155; 156). 
The evidence on the inverse association between size at birth and BP in adulthood is 
based on office BPs. While traditionally interpreted as supporting the hypothesis of 
permanently raised resting BP levels originated in utero, differences in office BP 
levels might as well reflect reactivity to a stressful situation, so-called “white-coat 
hypertension”. This type of mechanism, which is, however, not exclusive of other 
hypertensive disease pathways, has been presented in subjects exposed to famine in 
utero in whom BP response to stress was increased (96). Instead, ambulatory 
measurements give a picture of BP over a 24-hour period. In our study the findings 
from BPs measured at the clinic were confirmed with ambulatory measurements 
made on a subsample. Reassuringly, the clinic and averaged ambulatory 
measurements were highly correlated. Furthermore, comparably to our findings on 
birth size and office BP, among all study subjects a 1 kg increase in birth weight was 
associated with a 3.9 mmHg decrease in mean systolic ambulatory BP and, again, 
this association with a 9.4 mmHg decrease was confined to people with 
hypertension. This large difference occurred despite the subjects being on treatment 
for hypertension. These findings were not repeated in a study on quartiles of birth 
weight in relation to ambulatory measurements in 70-year-old men, of whom 24% 
were treated for hypertension (156).  
 
61 
There were no similar trends with diastolic pressure. With increasing age, pulse 
pressure widens through rising systolic pressure. Diastolic pressure does not tend to 
rise, and one would not therefore expect it to be linked to self-perpetuating processes 
that act on blood pressure and are associated with aging. In accordance with our 
results, previous studies have reported weak or lacking associations of birth weight 
with diastolic BP (153). Furthermore, presumably many studies have not presented 
data on diastolic BP because of lack of a significant association. 
Another novel finding was that the inverse association between birth weight and 
systolic BP level among hypertensive people was confined to people with the 
Pro12Pro polymorphism of the PPAR-2 gene (9.3 mmHg/1 kg,). This finding 
underscores the importance of genetic background and gene-environment 
interactions on the association of early growth and adult health, and guides further 
research on the mechanisms behind these associations, given the important role of 
this gene in the control of energy, glucose and lipid homeostasis. Because of the 
high prevalence of the Pro12Pro polymorphism (68% of all and a similar percentage 
of hypertensive subjects in our study sample) (164), even a small effect interacting 
with birth weight on BP translates into a large risk at the population level. 
6.1.2 Programming of hypertension; suggested background mechanisms 
Self-perpetuating cycle initiated in utero and amplified by age-related damage 
In addition to systolic BP level, birth size has been associated with established 
hypertension (126). In that study in the Helsinki Birth Cohort, people were defined 
hypertensive if they were receiving reimbursement for antihypertensive medication, 
which in Finland is reserved for those with more severe or complicated 
hypertension. They were shown to have lower birth weight and shorter body length 
at birth than did other people (126). The present results were consistent with this 
association with established hypertension, and the hypothesis that slow growth in 
utero initiates a self-perpetuating mechanism that leads to hypertension.  
The results suggest that during early adult life the various regulatory mechanisms 
controlling BP ensure that the pathological processes associated with poor fetal 
growth lead only to a small increase in BP. In older people, however, damages 
related to age begin a vicious cycle of rising BP, further damages, and eventually the 
development of hypertension, amplified by the self-perpetuating cycle. People with 
lesions acquired in utero are more vulnerable to this process, and the inverse 
association between birth weight and BP becomes focused on this group. This 
framework of ideas may illuminate the paradox that low birth weight has only small 
effects on BP levels in the general population (50), but has large effects on age-
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related risk of hypertension and morbidity and mortality from cardiovascular disease 
(12; 13). However, according to the Uppsala studies, mortality from cardiovascular 
disease is not mediated directly through an increased blood pressure in men with 
low birth weight (225).  
Two possible self-perpetuating mechanisms involve nephron numbers and arterial 
elastin. The number of nephrons each person has at birth varies widely, from 
300 000 to 1 100 000 (226). Small babies have fewer nephrons, which, combined 
with age-related nephron loss, could lead to a self-perpetuating cycle of rising BP 
and nephron loss (97; 99). Alternatively, people who were small at birth have been 
shown to have less elastic arteries (103). The elasticity of larger arteries depends on 
the scleroprotein elastin, which is laid down in utero and during infancy and 
thereafter turns over slowly. Its half-life in humans is approximately 40 years. 
Reduced elastin deposition in small babies leads to stiffness in the major arteries, 
which leads to raised pulse pressure. The loss of elastin with aging will amplify this 
increase in pulse pressure. It can readily be shown that stiffer, less compliant arteries 
alter the pressure wave generated by the contraction of the heart in such a way that 
systolic BP increases while diastolic BP tends to fall (227). 
Since the ambulatory BP recording was performed during ongoing treatment, higher 
systolic BP in hypertensive subjects with low birth weight compared with those with 
high birth weight may be interpreted as a weaker response to antihypertensive 
medication. Among these hypertensive people on medication, a majority received 
beta-adrenergic receptor blockers and 44% diuretics while approximately one third 
received either calcium channel antagonists or ACEI/ARBs, 49% being on 
combination therapy. The degree of response to different antihypertensive 
medications may guide the search for possible pathophysiologic mechanisms behind 
the association of low birth weight and high BP in later life. Unfortunately, in our 
study the numbers of people on different medications with available ambulatory 
recordings were too small to assess the BP responses according to birth size.  This 
kind of study would also require a prospective setting with a recent onset of 
hypertension and preferably only one class of medication in use at a time. 
Gene-environment interactions 
The self-perpetuating cycle may be further modified by interactions between gene 
polymorphisms and early environment. Low birth weight has been shown to have a 
large effect on insulin resistance among people with the common Pro12Pro 
polymorphism of the PPAR2-gene (164). We showed that low birth weight also 
had a strong effect on systolic BP levels in hypertensive Pro12Pro carriers but not in 
hypertensive carriers of the Ala-allele. A synthesis of these two observations might 
be that insulin resistance influences the renin-angiotensin-aldosterone system, which 
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has been perturbed by the reduced nephron numbers that accompany small body size 
at birth (97; 99; 100). Insulin up-regulates angiotensin II type 1 receptor gene 
expression, leading to enhanced signalling by angiotensin II, which is a potent 
vasoconstrictor (228). Angiotensin II inhibits insulin signalling (229; 230), which 
may further increase insulin resistance, leading to a vicious cycle of rising blood 
pressure and increasing insulin concentrations. 
The importance of renin-angiotensin-aldosterone system in the development of 
hypertension linked to early growth is further highlighted by our finding that among 
people on antihypertensive medication people with low birth weight were more 
likely to be receiving ACEI/ARB. This is consistent with previous findings on 
Caucasian men (157). This association, and a similar one with birth length, was, 
again, confined to people with the Pro12Pro polymorphism. If blood pressure levels 
in these people are elevated by an interaction between insulin resistance and the 
renin-angiotensin-aldosterone system, ACEI/ARB might be an appropriate therapy. 
This could not be tested in our cross-sectional setting. Another possible explanation 
for the use of ACEI/ARB in people who had low birth weight is that low birth 
weight is linked to co-morbid conditions such as myocardial infarction, congestive 
heart failure and type 2 diabetes that indicate the use of these medications. However, 
also animal experiments suggest a role of the renin-angiotensin system in the 
pathogenesis of hypertension that is attributable to experiences in utero (45; 231). 
The hypothesis of fetal programming has been challenged by an alternative 
explanation, the fetal insulin hypothesis. This hypothesis suggests that genetically 
determined insulin resistance may lead to both low birth weight and increased risk of 
hypertension, atherosclerosis and type 2 diabetes in adult life (232). The common 
genetic background would therefore explain the association between low birth weight 
and insulin resistance. As the insulin-sensitizing Ala-allele of the PPAR2 gene has 
been associated with higher birth weight and ponderal index (233), this gene is a 
potential candidate gene to test this hypothesis. In our study and in a German study 
(234) the Pro12Ala polymorphism was not related to higher birth weight. However, 
only among those with small body size at birth, the carriers of the Ala-allele were 
protected against insulin resistance (235), indicating gene-environment interaction 
since fetal life, rather than common genetic background for low birth weight and 
insulin resistance. As the hypotheses are not mutually exclusive, the role of genes and 
gene polymorphisms in programming deserves more attention. 
Adult body size and blood pressure; role of birth size 
The strong association between high current BMI and elevated BP has been 
described repeatedly. In our study this association was confined to people who were 
not hypertensive. Similarly, the strong associations between elevated BP and large 
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waist circumference and high percentage body fat were confined to normotensive 
people. The absence of an association between indicators of obesity and BP in 
hypertensive patients suggests that a reduction in body fat might be of less 
importance in relation to BP control in aged hypertensive patients than it is in the 
general population. However, it is well established that weight control and reduction 
in cardiometabolic risk improvement is essential. Plausibly the effects of high fat 
mass on raised BP are masked in these 65-75 year old hypertensive subjects by the 
effects of the self-perpetuating processes linked to poor growth in utero.  
6.1.3 Birth size and glucose tolerance; role of regular physical activity 
Regular and moderate habitual exercise protected against glucose intolerance in 
elderly people who were at increased risk of developing type 2 diabetes because 
they were born thin or small. The sufficient intensity of exercise was comparable to 
brisk walking. 
Despite the different dichotomization of leisure-time physical activity, these results 
are in line with another study on middle-aged Finnish men in whom the associations 
of thinness at birth with fasting insulin and glucose levels, the insulin sensitivity 
index and the metabolic syndrome, detected in the whole study group, were absent 
in men engaging in at least 25 min/week of strenuous leisure-time physical activity 
(130). In more sedentary men the association of thinness at birth with 
hyperinsulinemia was enhanced making the interaction of physical activity and the 
ponderal index significant. In that study objectively measured cardiovascular fitness 
also modified these associations comparably. In another study physical activity in 
low birth weight subjects did not reduce the risk of having at least two components 
of the metabolic syndrome (133). Because that definition did not necessarily include 
glucose intolerance, which was defined as HbA1c  6.2%, the results are not fully 
comparable. In addition, younger age (mean of 36 years), inclusion of other than 
leisure-time activity such as work-related activities, and use of self-reported birth 
weights may explain why there was no reduction in the risk. 
Insulin resistance is an important and rapidly increasing condition worldwide and is 
potentially the underlying pathophysiological factor for a large number of chronic 
diseases, like the metabolic syndrome, type 2 diabetes and cardiovascular disease. 
Although genetic and early environmental factors are of importance in the 
development of insulin resistance, the main determinants are modifiable lifestyle 
factors. Treatment and prevention of insulin resistance and glucose intolerance in 
high risk groups for type 2 diabetes is possible by regular and adequate exercise 
(185). Physical activity recommendations should be targeted specifically towards 
people who are likely to benefit particularly from exercise but first they need to be 
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identified. In this study people who were small at birth, and thus at high risk for 
glucose intolerance, gained a special benefit from exercise and should therefore be 
encouraged to maintain an active lifestyle. The exercise intensity that was needed is 
reasonable for most people.  
In addition to general insulin resistance and type 2 diabetes, a small body size at 
birth is associated with muscular insulin resistance (1; 107; 109; 236). Improved 
insulin sensitivity, in turn, is central to the protective effect of exercise against type 
2 diabetes (185; 237-239) and might explain our findings. This is supported by the 
aforementioned study by Laaksonen et a. 2003 (130): the adverse effect of thinness 
at birth on a proxy for insulin resistance, the level of fasting insulin, was no longer 
evident in physically active men. Physical activity, by improving muscular insulin 
sensitivity through a variety of mechanisms, may be particularly beneficial for 
individuals born small and thus at risk for insulin resistance.  
The state of insulin resistance because of altered muscle metabolism in people born 
small may be further enhanced because of their lower lean mass which consists 
mainly of muscle mass. This is discussed in Chapter 6.1.4. At any level of adult 
BMI, people who were small at birth had a higher ratio of fat to lean body mass 
(114). Since muscle tissue is the most important tissue for the storage and oxidation 
of glucose, individuals with a higher fat to muscle ratio are at increased risk of the 
metabolic consequences of insulin resistance.  
Small body size at birth has been associated with not only changes in muscle mass 
and function but also with a reduced cardiopulmonary capacity (1), which 
theoretically could influence willingness to exercise. Indeed, in 12 year old subjects 
birth weight and aerobic fitness were positively related (186), but, however, in 
middle-aged Finnish men thinness at birth was not associated with physical activity 
or cardiorespiratory fitness (130). We did not measure fitness, but, interestingly, in 
our study elderly men with a small body size at birth exercised more frequently and 
with higher intensity than the men with a larger body size at birth. In our elderly 
high-risk subjects, this might represent the survival of the fittest.   
6.1.4 Birth size, change in childhood BMI and adult body composition 
Adult body composition was assessed by a bioelectrical impedance analysis (BIA). 
In men and women aged 56 to 70 years birth weight was positively related to adult 
lean body mass. The finding remained consistent after adjustment for body size, 
which is known to be associated with birth size, or confounding factors affecting the 
amount of lean mass such as physical activity, smoking and maternal height or BMI. 
During childhood the timing and magnitude of gain in standard deviations for BMI 
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had a significant impact on the adult body fat and lean compartments.  High BMI at 
birth, rapid gain in conditional z-scores for BMI in infancy, and in early and late 
childhood up to the age 11 years, were independently related to higher adult height-
normalized lean mass index, LMI. Higher adult fat mass index (FMI) was predicted 
only by rapid increase in BMI beginning after 2 years of age. These findings provide 
further insight into the mechanisms that underlie the link between low birth weight 
or thinness at birth, childhood growth patterns and adult health outcomes.(143; 188-
190; 192) 
Lean mass 
The results of Studies IV and V are consistent with previous studies linking low 
birth weight with reduced lean body mass (111-117). Correspondingly, as in Study 
V, rapid childhood growth throughout childhood has been related with higher lean 
mass in later life (211-213). 
Fat mass  
High birth weight has been linked in a number of previous studies to high adult BMI 
which is a commonly used and reasonably valid index of fatness in population 
studies (143; 188-192). This has been counterintuitive, since whereas obesity has 
long been known to predispose to several diseases, including type 2 diabetes and 
cardiovascular disease, accumulating evidence has linked higher birth weight with a 
lower risk of these diseases (16; 126; 127). However, because BMI represents both 
lean and fat mass, a high BMI at an individual level does not necessarily indicate 
increased adiposity.  The limitations of BMI and the need for more specific 
measures of adiposity are increasingly recognized as illustrated by our study which 
used BIA to estimate total fat mass and body fat percentage. 
In Study IV birth weight was positively related to adult fat mass in men, but this 
association disappeared after adjustment for adult BMI. On the other hand, when 
current BMI was taken into account, it was low birth weight, not high, that predicted 
in both sexes higher adult body fat percentage.  In comparison, a study on elderly 
men at both ends of the birth weight distribution showed that men in the low-birth-
weight group had higher body fat percentage than men in the high-birth-weight 
group both before and after control for BMI (117). While our result suggests that the 
positive relationship of birth weight with adult BMI may not adequately predict the 
level of fatness, the impact of birth weight on fat percentage was relatively small 
and confined to men with a BMI below 30 kg/m2 and women with a BMI below 25 
kg/m2.  This might be partly explained by non-optimal adult lifestyle, including 
unhealthy dietary and exercise habits, leading to excess fat mass which overrides the 
effects of birth weight on fat percentage in obese individuals.  
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We found no relationship between infant or childhood growth rate before the age of 
2 years and adult fat mass, which is in contrast with three other studies (211-213). 
However, supporting the relative importance of rapid growth during later childhood 
in the development of adult fat mass, one of these studies reported that rapid gain in 
BMI early in childhood was more strongly related to lean mass than to adiposity in 
later life whereas another showed that rapid weight gain during later childhood, 
from 4 years onwards, was associated with the ratio of fat to lean. The dissimilarities 
in these studies might be explained to some extent by younger age, slenderness, 
different methodology, nutritional status of the population, and ethnic background of 
the subjects in these studies. We emphasize that in our study the adult adiposity-
related increase in expected growth rate between the ages 2 and 7 may have 
happened at any age during this period. This period was not split up into shorter 
ones because the limited number of measurements between 2 and 7 years might 
have introduced error. The age of increase in growth rate may differ between sexes: 
in the Fels Longitudinal Study the BMI values diverged at age 3 years in boys and 9 
years in girls between adults ( mean age 51 years) who became or did not become 
obese (BMI  30) (240). We also stress that, despite the adult adiposity-related rapid 
gain in BMI between 2 and 11 years of age, only a small minority of our subjects 
were overweight and none were obese as children according to the contemporary 
BMI references (224). 
Waist circumference 
Waist circumference has been suggested as a reasonable indicator of visceral fat in 
studies validating anthropometric measures against abdominal computerized 
tomography (241). Two other studies have assessed, in European subjects, the 
relationship between birth weight and waist circumference unadjusted and adjusted for 
BMI (202; 204). Consistent with these studies, we found a positive association between 
birth weight and waist circumference in men (202; 204) but not in women (204). This 
association remained significant after adjustment for BMI in one study (204).  
Grip strength 
We extended the assessment of early life origins of adult body composition to that of 
muscle strength. As could be expected from the strong relationship between birth 
weight and lean mass - which consists mainly of muscle mass - grip strength was 
stronger by higher birth weight. The results on grip strength in itself were 
comparable with a previous study on Californian population (242) but lower than in 
a British cohort (243), the members of which were 3-17 years younger than our 
subjects. The association between birth weight and grip strength has been observed 
previously (116; 243; 244). Two of these studies reported adjustments for adult 
height and weight which did not explain the birth weight association (243; 244). We 
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found that this relationship disappeared after adjustment for lean mass, suggesting 
that the effects of prenatal conditions, indicated by birth weight, on muscle strength 
are mediated through effects on gross muscle mass. 
Public health implications  
Low birth weight is an established risk factor for type 2 diabetes and cardiovascular 
disease (16; 64; 127) which are leading causes of morbidity and mortality in western 
countries. Developmental alterations in body composition have been suggested as 
one of the mechanisms behind this increased risk. In these 56-70 year old men and 
women, high birth weight or BMI, and rapid gain in BMI before the age of 2 years, 
predicted higher lean mass but not fat mass, whereas rapid growth thereafter was 
related to relatively larger increase in fat mass; fetal or infancy poor gain in weight 
or BMI might predispose to disproportionately low adult lean mass. Since lean mass 
consists primarily of muscle tissue, which is a major site for insulin-mediated 
glucose metabolism, low lean mass may further predispose to an early and central 
feature of the cardiometabolic disorders, reduced insulin sensitivity.  
A growth pattern with poor fetal or infant growth followed by later catch-up in 
weight or BMI seems to aggravate the risk of insulin resistance (19; 70; 171; 197; 
199-201; 245) and adverse adult health outcomes including glucose intolerance and 
coronary heart disease (13; 64; 65; 71; 74; 246). Consistently, studies from countries 
undergoing the nutritional transition have shown that growth failure in early 
childhood together with development of overweight in later childhood is associated 
with several cardiometabolic risk factors in early adulthood (247). There may be  
critical windows for consequences of changes in growth rate: a recent study in obese 
10-year old children showed that high weight gain between birth and 2 years of age, 
independent of birth weight, increased insulin sensitivity whereas high weight gain 
after 4 years of age favored insulin resistance (144). According to Study V, after the 
age of 2 years a rapid gain in BMI favors accumulation of fat mass. Since adipose 
tissue has been acknowledged as a metabolically active tissue secreting several 
agents that regulate processes involved in carbohydrate and fat metabolism (248), 
dysfunction of increased fat mass, particularly in subjects with low compensatory 
lean mass due to slow fetal and infancy growth, may thus induce insulin resistance 
promoting the development of type 2 diabetes and cardiovascular disease.  
These studies illuminate the limitations of BMI as an indicator of fatness in life 
course studies assessing the relationship between early growth and obesity. Higher 
risk of obesity in later life, as assessed mainly by BMI, has been associated with 
rapid weight gain in infancy (60; 142; 249-251). In the Helsinki Birth Cohort Study 
the growth pattern leading to obesity was different from that related to 
cardiometabolic diseases: children who later gained weight to exceed a BMI 30 in 
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adult life had above-average and increasing z-scores for BMI at all ages from birth 
to 12 years of age (143). However, since BMI does not distinguish between lean and 
fat mass, studies assessing obesity by BMI should be interpreted with caution. 
Studies IV and V showed that high birth weight, and rapid weight or BMI gain 
throughout infancy and childhood, predicted higher adult lean mass and thus 
increased the likelihood of exceeding the obesity cut-off of BMI. The limitations of 
BMI as an outcome measure in studies assessing obesity has  also been illustrated in 
children and adolescents aged 8 to 18 years, in whom increases in BMI percentile 
across the whole range reflected uniform increases in fat free mass, whereas percent 
body fat tended to increase dramatically only at higher BMI percentiles (252). That 
study also suggested that, even in the overweight range, BMI may reflect different 
degrees of fatness in boys versus girls and in younger versus older children. 
A key difference between obese subjects who are metabolically healthy and those 
who have diabetogenic and atherogenic metabolic abnormalities might be abdominal 
obesity (253), specifically accumulation of visceral fat, which is closely related to 
insulin resistance (254; 255). A period of pre- or postnatal poor growth has been 
shown to alter metabolism to favor abdominal fat deposition (208) and fat gain 
instead of gain in lean mass during later growth (120; 208), thus possibly promoting 
the development of insulin resistance. Consistent with this hypothesis, the 
association between insulin resistance and low birth weight or thinness at birth has 
been shown to be amplified in subjects whose small size or thinness at birth was 
followed by later catch-up growth in BMI, independently of the development of 
actual obesity (19; 70; 171; 197; 199-201). In Study V, independent of earlier 
growth, a period of more rapid gain in BMI after, but not before the age of 2 years, 
predicted higher adult waist circumference which is a widely used proxy for 
abdominal obesity. However, the positive association between birth weight and 
waist circumference in men might seem to contradict with the hypothesis of low 
birth weight as a predictor of abdominal obesity. We believe that this discrepancy 
illustrates the importance of the use of specific indicators of body composition and 
fat distribution in life course studies; waist circumference cannot distinguish 
metabolically benign subcutaneous fat from metabolically dangerous visceral 
adipose tissue. Therefore we propose caution before drawing any conclusions on a 
question which would require more accurate methods such as computer tomography 
or magnetic resonance imaging to assess visceral fat.  
Grip strength in elderly people is an important indicator and predictor of frailty (256). 
The positive association between birth weight and grip strength suggests that early life 
programming may have an important role, not only in the development of 
cardiovascular disease and type 2 diabetes, but also in determining the frames of 
functional capacity in ageing individuals. The importance of this is growing due to the 
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continuous rise in life expectancy during the last decades (257). In addition to grip 
strength, the balance of fat and lean mass is important for functional ability at an older 
age (242; 258), and according to a prospective study in 60-year old men, mortality 
increases as a function of percentage of fat and decreases as a function of fat-free mass 
(259). However, the most important factor for physical performance and functional 
independence at an old age is the maintenance of physical activity (260). 
 
6.2 Limitations of the study 
6.2.1 Study design 
The developmental model of the origin of adult health and disease has prompted the 
kind of studies that explore the data on early growth in relation to adult outcomes. 
The observations in these clinic epidemiological studies are cross-sectional, and the 
detected associations do not indicate causality. Studies analyzing data on the two 
distant parts of the life span serve as surrogate for follow-up studies, which in this 
framework, considering the decades in between, are impractical. The suggested 
mechanisms can be tested by e.g. animal models. By combining data from different 
approaches we can advance the knowledge on the life course concept.  
6.2.2 Study population 
Subjects in these studies may not be representative of the general population born in 
Helsinki. The data is restricted to men and women who were born as singletons in 
the University Hospital, went to school in Helsinki, did not emigrate and were still 
alive in 1998-2003 (Studies I-III) or in 2001-4 (Studies V-V) and willing to 
participate. In addition, members of the younger cohort belong to the approximately 
60% of children who had attended the voluntary child welfare clinics. Regarding 
blood pressure and glucose tolerance status, we found it appropriate to study 65-75 
year old subjects since those predisposed to have hypertension or glucose 
intolerance are likely to have manifested these disorders by that age. On the other 
hand, by that age those people who were most susceptible to cardiovascular disease 
may already have died, creating a survivor’s bias. Similarly, our results could further 
be influenced by preferential survival of subjects with particular profiles of birth 
weight, growth profile, body composition, glucose and insulin metabolism, and 
blood pressure. However, our findings are based upon internal comparisons within 
the sample and are unlikely to be attributed to selection bias.  
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In Studies I and II the subsample on which the ambulatory blood pressure recording 
was performed was selected through the availability of monitoring equipment on the 
day of clinic attendance. The subsample may not have been representative of the 
study sample but their birth measurements, adult BMI and the proportion of 
hypertensive people were similar.  
Since the raise in BP level with early origin seems to be amplified by age (50), our 
findings on blood pressure and hypertension may be limited to elderly populations. 
Another concern is that these studies may have limited applicability to contemporary 
cohorts. Intergenerational effects may have modified the results; factors causing low 
birth weight may differ from those operating in contemporary cohorts, e.g. maternal 
smoking was rare. Men and women from the younger cohort were children around 
the Second World War and some of them may have suffered from food shortages. In 
addition, concerning Studies IV-V, children from historical cohorts may have 
different fatness for a given BMI compared with contemporary children (261).  
In Study I, classification as hypertensive was based on a self-reported diagnosis of 
hypertension by a physician; 18% were not currently on antihypertensive 
medication. Self-reported diagnosis may not be considered as reliable. However, 
when we classified subjects according to the use of antihypertensive medication or 
by clinic systolic BP 160 mmHg, the findings remained similar. Lower levels of 
clinic systolic BP categorized the majority of the people as hypertensive but the 
interaction between birth weight and hypertension on BP remained.  
In Study II, all the subjects who reported the use of antihypertensive medication, 
irrespective of diagnosis, were included in the analyses. As an example, some of 
them may have used beta-adrenergic receptor blockers for coronary heart disease 
and not for hypertension. Also in this case the definition of hypertension was 
unlikely to cause bias since the findings remained stable when we excluded people 
without a diagnosis of hypertension. 
82 of the 208 hypertensive subjects were receiving 2 or more antihypertensive 
agents, which may have affected our results on the relationship between birth size 
and the use of antihypertensive medication. However, in those on monotherapy, both 
in the whole study sample and in the Pro12Pro carriers, the relationship between 
birth size and the use of ACEI/ARB could be detected despite the small number (16 
and 15, respectively) of these subjects. 
6.2.3 Measurements 
The estimate of blood pressure level was based on a mean of two consecutive 
measurements in the same morning, with medication taken during the previous day. 
 
72 
An optimal estimate would require measurements on several days. However, mean 
systolic BP levels in a subsample with a 24-h ambulatory recording during 
medication showed similar results. This finding also indicated that medication for 
elevated BP could not mask the effect of birth size on systolic BP levels in 
hypertensive subjects. 
Exercise habits are difficult to measure and no globally acceptable methods exist. 
For internal comparisons in this sample, we used two questions and a questionnaire 
by which subjects were divided into two groups according to their physical activity.  
Since exercise and physical activity habits, and consequently questionnaires, are 
culture dependent, we used the KIHD questionnaire validated in Finland (214), 
although only in men who were younger than the men in our study. The 12-month 
questionnaire has a representative time frame and a relatively small intra-person 
variability and is therefore suitable for the assessment of leisure time physical 
activity. All methods gave comparable results. 
Body composition was measured by bioelectrical impedance analysis (BIA). The 
eight-polar BIA has been shown to give accurate estimates of body components in 
different populations without the need for population-specific algorithms (216-219). 
This method is practical in large epidemiological studies with limited time for 
examination of each subject (216; 217). 
An obvious challenge for all body composition studies is that absolute measures 
such as lean or fat mass represent not only the proportion of that compartment but 
also body size itself.  Birth weight is known to be related with adult body size: the 
heavier the newborn, the higher the height and BMI in adulthood (143; 188-192). In 
Study IV, we addressed this problem by adjusting analyses for adult height, which is 
closely related to the amount of lean mass, or BMI, which represents both lean and 
fat mass. In Study V we used height-normalized indices of adult lean and fat mass 
(221; 222). Age was included in these models since fat mass tends to increase and 
lean mass to decrease with age, even when weight remains stable (262). The 
association between high birth weight or BMI and greater lean mass in adulthood 
persisted independently of these adjustments.  Thus, birth weight predicts lean body 
mass even within adults of the same sex and height or BMI.  
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7 CONCLUSIONS  
The findings in the thesis studies illustrate the complex nature of the developmental 
origins of adult health and disease. A particular gene polymorphism, established 
hypertension, childhood growth pattern and adult habitual physical activity level 
were shown to modify the associations between early growth and the adult outcome. 
This may help to explain why some people with adverse experiences during early 
life, as indicated by small birth size or poor growth in infancy, develop e.g. 
hypertension or diabetes while other people with corresponding early predisposition 
are protected from the actual disease.  In addition to early growth, another common 
theme in these studies was insulin resistance: blood pressure regulation, PPAR2 
gene Pro12Ala polymorphism, glucose tolerance, exercise habits, absolute and 
relative amounts of lean and fat body mass are all related to insulin sensitivity, 
which plays a major role in the development of the metabolic syndrome.  
Among elderly men and women with established hypertension, size at birth had a 
strong effect on systolic BP levels whereas there was no relationship in people 
without hypertension. This finding illuminates the paradox that the negative 
association between birth weight and systolic BP is in general small, 2-4 mmHg in 
elderly subjects, while the low birth weight -related risk of hypertensive disease is 
substantial. Pathological features of BP regulation, originated during fetal life, are 
suggested to become self-perpetuating in adult life, eventually leading to 
hypertension. The highest systolic BP levels in hypertensive people were predicted 
by prevailing Pro12Pro polymorphism of the PPAR2 gene together with low birth 
weight, indicating gene-environment interactions on BP levels that originate during 
fetal life. Because both the Pro12Pro genotype and low birth weight, individually 
and specifically in combination, have been related with higher insulin resistance, 
this mechanism may operate in the development of hypertension of an early origin. 
An interaction with the renin-angiotensin-aldosterone system is suggested by the 
finding that the hypertensive people with the Pro12Pro genotype and low birth 
weight were more likely to be receiving ACEI/ARB treatment. 
Habitual physical activity protected elderly men and women who were small at 
birth, and thus at increased risk for the development of type 2 diabetes, against 
glucose intolerance more strongly. Regular physical activity at a modest level may 
alleviate or eliminate metabolic consequences that are related to small birth size. The 
importance of this is further highlighted by the finding that sufficient exercise 
intensity was comparable to brisk walking and thus achievable by most people. The 
studies on early growth in relation to adult body composition suggested that rapid 
gain in BMI before the age of 2 years promotes an increase in adult lean body mass 
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without excess fat accumulation whereas rapid gain in BMI in later childhood, 
despite the concurrent rise in lean mass, results in a relatively larger increase in fat 




Research for this thesis was carried out at the Diabetes Unit of the Department of 
Health Promotion and Chronic Diseases Prevention, National Public Health 
Institute, Finland. I wish to thank Professor Jussi Huttunen, the former Head of the 
Institute, and his successor Professor Pekka Puska, and Professor Erkki Vartiainen, 
the Head of the Department, for providing excellent research facilities. 
I owe my profound gratitude to my supervisors: Professor Jaakko Tuomilehto, in 
particular for introducing me to scientific research and encouraging me towards 
independent work, and my principal supervisor Professor Johan Eriksson, for his 
enthusiasm and ability to inspire and help me navigate through the jungle of data and 
results. Their ability to foresee important fields of research has been a great asset. 
I sincerely thank my official reviewers, Professors Mauno Vanhala and Leo 
Niskanen, for the smooth review process including valuable advice and constructive 
criticism, and Professor Marjo-Riitta Järvelin for accepting the role of Opponent in 
my thesis defence. 
I am very grateful for the fruitful collaboration with the scientists at the MRC 
Environmental Epidemiology Unit in Southampton, UK. I am impressed by 
Professor David Barker’s profound knowledge on this field of research and the 
speed at which his mind works. I truly appreciate the statistical expertise provided 
by Clive Osmond that smoothed and sped up my way considerably.  
My gratitude goes, in addition, to all the following persons: 
Tom Forsén, for laying the foundation of the Helsinki Birth Cohort Study databases 
and register linkages, and for advice in navigating among them; Eero Kajantie, 
whose educational skills in visualizing the study context as a whole as well as in 
making statistical, pediatric and other complex details comprehensible assisted me 
greatly. Regarding his productiveness and vast scope of interests in and beyond the 
scientific field, I wonder how he always had time for his friends and colleagues. 
Sigrid Rostén, who has shared a working room with me through all these years and 
proved to be good company, for expert data managing and prompt answers to any 
questions; research nurses Paula Nyholm, Terttu Nopanen and Terhi Eerola, for 
efficiently organizing and carrying out the clinical examinations of the study 
population; Liisa Saarikoski, for her social and organisatory skills; Pirjo 
Saastamoinen and Terttu Puskala, for help in various practical matters. All staff 
involved with the IDEFIX-project or working at the Diabetes Unit of the NPHI, of 
 
76 
whom Jaana Lindström and Valma Harjutsalo have given valuable practical tips for 
preparing the thesis. 
My fellow researchers Hanna Alastalo, Petteri Hovi, Maria Paile-Hyvärinen, Minna 
Salonen, Sonja Strang-Karlsson, and all the psychologists at the University of 
Helsinki as well as all the above-mentioned, for inspiring and welcoming 
athmosphere with plenty of humour. They have widened my insight and 
perspectives of research and life. 
My husband Jyri Juslén, for proofreading my thesis and looking after our children 
during the evenings and weekends that I was off finalising my work. 
Pirjo Sintonen and Eija Lahdensuo, for keeping me in touch with clinical work 
outside the thesis project. Working with them was truly enjoyable, not to mention all 
the laughs during breaks. 
All the 2503 participants of the clinical studies - without them this thesis would not exist. 
Financial support for this study has been provided by the Academy of Finland, 
British Heart Foundation, Doctoral Programs in Public Health, Finnish Diabetes 
Research Foundation, Finnish Foundation for Cardiovascular Research, Finnish 
Medical Society Duodecim, Finska Läkaresällskapet, Jalmari and Rauha Ahokas 
Foundation, Juho Vainio Foundation, Päivikki and Sakari Sohlberg Foundation, 
Signe and Ane Gyllenberg Foundation, and Yrjö Jahnsson Foundation. 
 
 






1. Barker DJP: Mothers, babies and health in later life. Edinburgh, Churchill Livingstone, 1998 
2. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic 
syndrome.  April 14, 2005 http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf.  
3. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome--a new worldwide definition. Lancet 
366:1059-1062, 2005 
4. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ: Weight in infancy and death 
from ischaemic heart disease. Lancet 2:577-580, 1989 
5. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM: Type 2 (non-insulin-
dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced 
fetal growth. Diabetologia 36:62-67, 1993 
6. Barker DJ, Osmond C, Simmonds SJ, Wield GA: The relation of small head circumference and 
thinness at birth to death from cardiovascular disease in adult life. Bmj 306:422-426, 1993 
7. Fall CH, Osmond C, Barker DJ, Clark PM, Hales CN, Stirling Y, Meade TW: Fetal and infant 
growth and cardiovascular risk factors in women. Bmj 310:428-432, 1995 
8. Law CM, Barker DJ, Bull AR, Osmond C: Maternal and fetal influences on blood pressure. 
Arch Dis Child 66:1291-1295, 1991 
9. Kramer MS, Joseph KS: Enigma of fetal/infant-origins hypothesis. Lancet 348:1254-1255, 1996 
10. Paneth N, Susser M: Early origin of coronary heart disease (the "Barker hypothesis"). Bmj 
310:411-412, 1995 
11. Huxley R, Neil A, Collins R: Unravelling the fetal origins hypothesis: is there really an inverse 
association between birthweight and subsequent blood pressure? Lancet 360:659-665, 2002 
12. Koupilova I, Leon DA, Lithell HO, Berglund L: Size at birth and hypertension in 
longitudinally followed 50-70-year-old men. Blood Press 6:223-228, 1997 
13. Eriksson JG, Forsén T, Tuomilehto J, Osmond C, Barker DJ: Early growth and coronary heart 
disease in later life: longitudinal study. Bmj 322:949-953, 2001 
14. Forsén T, Eriksson JG, Tuomilehto J, Osmond C, Barker DJ: Growth in utero and during 
childhood among women who develop coronary heart disease: longitudinal study. Bmj 319:1403-
1407, 1999 
15. Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD: Birthweight, body-mass index in 
middle age, and incident coronary heart disease. Lancet 348:1478-1480, 1996 
16. Leon DA, Lithell HO, Vagero D, Koupilova I, Mohsen R, Berglund L, Lithell UB, McKeigue 
PM: Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort 
study of 15 000 Swedish men and women born 1915-29. Bmj 317:241-245, 1998 
 
78 
17. Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett 
WC, Hennekens CH: Birth weight and risk of cardiovascular disease in a cohort of women 
followed up since 1976. Bmj 315:396-400, 1997 
18. Stein CE, Fall CH, Kumaran K, Osmond C, Cox V, Barker DJ: Fetal growth and coronary 
heart disease in south India. Lancet 348:1269-1273, 1996 
19. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA: Relation of size at 
birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Bmj 
312:406-410, 1996 
20. Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Gillman MW, Hennekens CH, 
Speizer FE, Manson JE: Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann 
Intern Med 130:278-284, 1999 
21. Cooper C, Eriksson JG, Forsen T, Osmond C, Tuomilehto J, Barker DJ: Maternal height, 
childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int 12:623-
629, 2001 
22. Cheung YB, Khoo KS, Karlberg J, Machin D: Association between psychological symptoms 
in adults and growth in early life: longitudinal follow up study. Bmj 325:749, 2002 
23. Paile-Hyvärinen M, Räikkönen K, Forsén T, Kajantie E, Ylihärsilä H, Salonen MK, Osmond 
C, Eriksson JG: Depression and its association with diabetes, cardiovascular disease, and birth 
weight. Ann Med:1-7, 2007 
24. Räikkönen K, Pesonen AK, Kajantie E, Heinonen K, Forsén T, Phillips DI, Osmond C, Barker 
DJ, Eriksson JG: Length of gestation and depressive symptoms at age 60 years. Br J Psychiatry 
190:469-474, 2007 
25. Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Vanhala M: Metabolic 
syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin 
Psychiatry 69:178-182, 2008 
26. McIntyre RS, Soczynska JK, Konarski JZ, Woldeyohannes HO, Law CW, Miranda A, Fulgosi 
D, Kennedy SH: Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type 
II"? Ann Clin Psychiatry 19:257-264, 2007 
27. Wahlbeck K, Forsen T, Osmond C, Barker DJ, Eriksson JG: Association of schizophrenia with 
low maternal body mass index, small size at birth, and thinness during childhood. Arch Gen 
Psychiatry 58:48-52, 2001 
28. Gunnell D, Harrison G, Whitley E, Lewis G, Tynelius P, Rasmussen F: The association of fetal 
and childhood growth with risk of schizophrenia. Cohort study of 720,000 Swedish men and 
women. Schizophr Res 79:315-322, 2005 
29. Kajantie E, Phillips DI, Osmond C, Barker DJ, Forsen T, Eriksson JG: Spontaneous 
hypothyroidism in adult women is predicted by small body size at birth and during childhood. J 
Clin Endocrinol Metab 91:4953-4956, 2006 
 
79 
30. Canoy D, Pekkanen J, Elliott P, Pouta A, Laitinen J, Hartikainen AL, Zitting P, Patel S, Little 
MP, Järvelin MR: Early growth and adult respiratory function in men and women followed from 
the fetal period to adulthood. Thorax 62:396-402, 2007 
31. McCormack VA, dos Santos Silva I, Koupil I, Leon DA, Lithell HO: Birth characteristics and 
adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer 115:611-
617, 2005 
32. Hilakivi-Clarke L, Forsen T, Eriksson JG, Luoto R, Tuomilehto J, Osmond C, Barker DJ: 
Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J 
Cancer 85:1680-1684, 2001 
33. Gluckman P, Hanson, MA.: The Fetal Matrix: evolution, development, and disease. 
Cambridge, Cambridge University Press, 2004 
34. Gilbert SF: Mechanisms for the environmental regulation of gene expression: ecological 
aspects of animal development. J Biosci 30:65-74, 2005 
35. Deeming DC, Ferguson MW: Environmental regulation of sex determination in reptiles. Philos 
Trans R Soc Lond B Biol Sci 322:19-39, 1988 
36. Ferguson MW, Joanen T: Temperature of egg incubation determines sex in Alligator 
mississippiensis. Nature 296:850-853, 1982 
37. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, Bleker OP: 
Glucose tolerance in adults after prenatal exposure to famine. Lancet 351:173-177, 1998 
38. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Schroeder-Tanka JM, 
van Montfrans GA, Michels RP, Bleker OP: Coronary heart disease after prenatal exposure to the 
Dutch famine, 1944-45. Heart 84:595-598, 2000 
39. Roseboom TJ, van der Meulen JH, Ravelli AC, Osmond C, Barker DJ, Bleker OP: Effects of 
prenatal exposure to the Dutch famine on adult disease in later life: an overview. Mol Cell 
Endocrinol 185:93-98, 2001 
40. Gluckman PD, Hanson MA, Spencer HG, Bateson P: Environmental influences during 
development and their later consequences for health and disease: implications for the interpretation 
of empirical studies. Proc Biol Sci 272:671-677, 2005 
41. Lucas A, Fewtrell MS, Cole TJ: Fetal origins of adult disease-the hypothesis revisited. Bmj 
319:245-249, 1999 
42. Anway MD, Rekow SS, Skinner MK: Transgenerational epigenetic programming of the 
embryonic testis transcriptome. Genomics, 2007 
43. Drake AJ, Walker BR, Seckl JR: Intergenerational consequences of fetal programming by in utero 
exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol 288:R34-38, 2005 
44. Eriksson JG: Epidemiology, genes and the environment: lessons learned from the Helsinki 
Birth Cohort Study. J Intern Med 261:418-425, 2007 
45. Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ: Epigenetic modification of the renin-
angiotensin system in the fetal programming of hypertension. Circ Res 100:520-526, 2007 
 
80 
46. Weaver IC: Epigenetic programming by maternal behavior and pharmacological intervention. 
Nature versus nurture: let's call the whole thing off. Epigenetics 2:22-28, 2007 
47. Kajantie E: Mechanisms of growth in small preterm infants and early life origins of adult 
cardiovascular disease. University of Helsinki, 2003 
48. Dunkel L: Lastenendokrinologien käsikirja, 2005. 
http://www.lastenendokrinologit.net/kirja/index.html 
49. Karlberg J, Jalil F, Lam B, Low L, Yeung CY: Linear growth retardation in relation to the 
three phases of growth. Eur J Clin Nutr 48 Suppl 1:S25-43; discussion S43-24, 1994 
50. Gamborg M, Byberg L, Rasmussen F, Andersen PK, Baker JL, Bengtsson C, Canoy D, 
Droyvold W, Eriksson JG, Forsen T, Gunnarsdottir I, Järvelin MR, Koupil I, Lapidus L, Nilsen TI, 
Olsen SF, Schack-Nielsen L, Thorsdottir I, Tuomainen TP, Sörensen TI: Birth weight and systolic 
blood pressure in adolescence and adulthood: meta-regression analysis of sex- and age-specific 
results from 20 Nordic studies. Am J Epidemiol 166:634-645, 2007 
51. Phillips DI: Programming of the stress response: a fundamental mechanism underlying the 
long-term effects of the fetal environment? J Intern Med 261:453-460, 2007 
52. Gluckman PD, Hanson MA: Maternal constraint of fetal growth and its consequences. Semin 
Fetal Neonatal Med 9:419-425, 2004 
53. Kirchengast S, Hartmann B: Impact of maternal age and maternal somatic characteristics on 
newborn size. Am J Hum Biol 15:220-228, 2003 
54. Ounsted M, Scott A, Moar VA: Constrained and unconstrained fetal growth: associations with 
some biological and pathological factors. Ann Hum Biol 15:119-129, 1988 
55. Ong KK, Preece MA, Emmett PM, Ahmed ML, Dunger DB: Size at birth and early childhood 
growth in relation to maternal smoking, parity and infant breast-feeding: longitudinal birth cohort 
study and analysis. Pediatr Res 52:863-867, 2002 
56. Drake AJ, Walker BR: The intergenerational effects of fetal programming: non-genomic 
mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol 180:1-
16, 2004 
57. Tanner J: Growth as a target-seeking function: catch-up and catch-down growth in man. In 
Human growth: a comprehensive treatise, 2nd ed. Falkner F, Ed. New York, Plenum Press, 1986, 
p. 167-179 
58. Karlberg J, Albertsson-Wikland K: Growth in full-term small-for-gestational-age infants: from 
birth to final height. Pediatr Res 38:733-739, 1995 
59. Ezzahir N, Alberti C, Deghmoun S, Zaccaria I, Czernichow P, Levy-Marchal C, Jaquet D: 
Time course of catch-up in adiposity influences adult anthropometry in individuals who were born 
small for gestational age. Pediatr Res 58:243-247, 2005 
60. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB: Association between postnatal 
catch-up growth and obesity in childhood: prospective cohort study. Bmj 320:967-971, 2000 
 
81 
61. Kuh DL, Power C, Rodgers B: Secular trends in social class and sex differences in adult 
height. Int J Epidemiol 20:1001-1009, 1991 
62. Hindmarsh PC, Geary MP, Rodeck CH, Kingdom JC, Cole TJ: Factors Predicting Ante- and 
Postnatal Growth. Pediatr Res, 2007 
63. Cianfarani S, Germani D, Branca F: Low birthweight and adult insulin resistance: the "catch-
up growth" hypothesis. Arch Dis Child Fetal Neonatal Ed 81:F71-73, 1999 
64. Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG: Trajectories of growth among 
children who have coronary events as adults. N Engl J Med 353:1802-1809, 2005 
65. Eriksson JG, Osmond C, Kajantie E, Forsén TJ, Barker DJ: Patterns of growth among children 
who later develop type 2 diabetes or its risk factors. Diabetologia 49:2853-2858, 2006 
66. Singhal A, Cole TJ, Fewtrell M, Kennedy K, Stephenson T, Elias-Jones A, Lucas A: 
Promotion of faster weight gain in infants born small for gestational age: is there an adverse effect 
on later blood pressure? Circulation 115:213-220, 2007 
67. Singhal A, Cole TJ, Fewtrell M, Deanfield J, Lucas A: Is slower early growth beneficial for 
long-term cardiovascular health? Circulation 109:1108-1113, 2004 
68. Stettler N, Stallings VA, Troxel AB, Zhao J, Schinnar R, Nelson SE, Ziegler EE, Strom BL: 
Weight gain in the first week of life and overweight in adulthood: a cohort study of European 
American subjects fed infant formula. Circulation 111:1897-1903, 2005 
69. Ekelund U, Ong KK, Linne Y, Neovius M, Brage S, Dunger DB, Wareham NJ, Rossner S: 
Association of weight gain in infancy and early childhood with metabolic risk in young adults. J 
Clin Endocrinol Metab 92:98-103, 2007 
70. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, Ness AR, Dunger DB: 
Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and 
plasma insulin-like growth factor-I levels. Diabetologia 47:1064-1070, 2004 
71. Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker DJ, Biswas SK, Ramji S, 
Prabhakaran D, Reddy KS: Relation of serial changes in childhood body-mass index to impaired 
glucose tolerance in young adulthood. N Engl J Med 350:865-875, 2004 
72. Barker DJ, Forsen T, Eriksson JG, Osmond C: Growth and living conditions in childhood and 
hypertension in adult life: a longitudinal study. J Hypertens 20:1951-1956, 2002 
73. Adair LS, Cole TJ: Rapid child growth raises blood pressure in adolescent boys who were thin 
at birth. Hypertension 41:451-456, 2003 
74. Law CM, Shiell AW, Newsome CA, Syddall HE, Shinebourne EA, Fayers PM, Martyn CN, de 
Swiet M: Fetal, infant, and childhood growth and adult blood pressure: a longitudinal study from 
birth to 22 years of age. Circulation 105:1088-1092, 2002 
75. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, Levy-Marchal C: Dynamic 
change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated 
with reduced fetal growth. Diabetologia 48:849-855, 2005 
 
82 
76. Lundgren EM, Cnattingius HM, Jonsson GB, Tuvemo TH: Linear catch-up growth does not 
increase the risk of elevated blood pressure and reduces the risk of overweight in males. J 
Hypertens 19:1533-1538, 2001 
77. Olsen EM, Petersen J, Skovgaard AM, Weile B, Jorgensen T, Wright CM: Failure to thrive: 
the prevalence and concurrence of anthropometric criteria in a general infant population. Arch Dis 
Child 92:109-114, 2007 
78. Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype 
hypothesis. Diabetologia 35:595-601, 1992 
79. Lucas A: Role of nutritional programming in determining adult morbidity. Arch Dis Child 
71:288-290, 1994 
80. Bertram CE, Hanson MA: Animal models and programming of the metabolic syndrome. Br 
Med Bull 60:103-121, 2001 
81. McMillen IC, Robinson JS: Developmental origins of the metabolic syndrome: prediction, 
plasticity, and programming. Physiol Rev 85:571-633, 2005 
82. Painter RC, de Rooij SR, Bossuyt PM, Simmers TA, Osmond C, Barker DJ, Bleker OP, 
Roseboom TJ: Early onset of coronary artery disease after prenatal exposure to the Dutch famine. 
Am J Clin Nutr 84:322-327; quiz 466-327, 2006 
83. Stein AD, Zybert PA, van der Pal-de Bruin K, Lumey LH: Exposure to famine during 
gestation, size at birth, and blood pressure at age 59 y: evidence from the Dutch Famine. Eur J 
Epidemiol 21:759-765, 2006 
84. Roseboom TJ, van der Meulen JH, Ravelli AC, van Montfrans GA, Osmond C, Barker DJ, Bleker 
OP: Blood pressure in adults after prenatal exposure to famine. J Hypertens 17:325-330, 1999 
85. Stein AD, Zybert PA, van de Bor M, Lumey LH: Intrauterine famine exposure and body 
proportions at birth: the Dutch Hunger Winter. Int J Epidemiol 33:831-836, 2004 
86. Stanner SA, Yudkin JS: Fetal programming and the Leningrad Siege study. Twin Res 4:287-
292, 2001 
87. Räikkönen K a, Kajantie E, Rautanen A, Eriksson JG: Metabolic syndrome. In Handbook of 
research methods in health psychology Luecken LJ a, Gallo LC, Ed., SAGE Publications, 
Thousand Oaks, 2008, p. 299-322 
88. Björntorp P: Insulin resistance: the consequence of a neuroendocrine disturbance? Int J Obes 
Relat Metab Disord 19 Suppl 1:S6-10, 1995 
89. Kajantie E, Feldt K, Raikkonen K, Phillips DI, Osmond C, Heinonen K, Pesonen AK, Andersson 
S, Barker DJ, Eriksson JG: Body size at birth predicts hypothalamic-pituitary-adrenal axis response 
to psychosocial stress at age 60 to 70 years. J Clin Endocrinol Metab 92:4094-4100, 2007 
90. Phillips DI, Walker BR, Reynolds RM, Flanagan DE, Wood PJ, Osmond C, Barker DJ, 
Whorwood CB: Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 
populations. Hypertension 35:1301-1306, 2000 
 
83 
91. Phillips DI, Jones A, Goulden PA: Birth weight, stress, and the metabolic syndrome in adult 
life. Ann N Y Acad Sci 1083:28-36, 2006 
92. Reynolds RM, Godfrey KM, Barker M, Osmond C, Phillips DI: Stress responsiveness in adult 
life: influence of mother's diet in late pregnancy. J Clin Endocrinol Metab 92:2208-2210, 2007 
93. Seckl JR: Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and 
the early life origins of adult disease. Steroids 62:89-94, 1997 
94. Everson SA, Kaplan GA, Goldberg DE, Salonen JT: Anticipatory blood pressure response to 
exercise predicts future high blood pressure in middle-aged men. Hypertension 27:1059-1064, 1996 
95. Kamarck TW, Everson SA, Kaplan GA, Manuck SB, Jennings JR, Salonen R, Salonen JT: 
Exaggerated blood pressure responses during mental stress are associated with enhanced carotid 
atherosclerosis in middle-aged Finnish men: findings from the Kuopio Ischemic Heart Disease 
Study. Circulation 96:3842-3848, 1997 
96. Painter RC, de Rooij SR, Bossuyt PM, Phillips DI, Osmond C, Barker DJ, Bleker OP, 
Roseboom TJ: Blood pressure response to psychological stressors in adults after prenatal exposure 
to the Dutch famine. J Hypertens 24:1771-1778, 2006 
97. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology of adult 
hypertension and progressive renal injury. Am J Kidney Dis 23:171-175, 1994 
98. Mackenzie HS, Lawler EV, Brenner BM: Congenital oligonephropathy: The fetal flaw in 
essential hypertension? Kidney Int Suppl 55:S30-34, 1996 
99. Manalich R, Reyes L, Herrera M, Melendi C, Fundora I: Relationship between weight at birth 
and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int 
58:770-773, 2000 
100. Hughson M, Farris AB, 3rd, Douglas-Denton R, Hoy WE, Bertram JF: Glomerular number 
and size in autopsy kidneys: the relationship to birth weight. Kidney Int 63:2113-2122, 2003 
101. Chen Y, Lasaitiene D, Friberg P: The renin-angiotensin system in kidney development. Acta 
Physiol Scand 181:529-535, 2004 
102. Flanagan DE, Moore VM, Godsland IF, Cockington RA, Robinson JS, Phillips DI: Reduced 
foetal growth and growth hormone secretion in adult life. Clin Endocrinol (Oxf) 50:735-740, 1999 
103. Martyn CN, Greenwald SE: Impaired synthesis of elastin in walls of aorta and large conduit 
arteries during early development as an initiating event in pathogenesis of systemic hypertension. 
Lancet 350:953-955, 1997 
104. Martin H, Gazelius B, Norman M: Impaired acetylcholine-induced vascular relaxation in low 
birth weight infants: implications for adult hypertension? Pediatr Res 47:457-462, 2000 
105. Gale CR, Jiang B, Robinson SM, Godfrey KM, Law CM, Martyn CN: Maternal diet during 




106. Goodfellow J, Bellamy MF, Gorman ST, Brownlee M, Ramsey MW, Lewis MJ, Davies DP, 
Henderson AH: Endothelial function is impaired in fit young adults of low birth weight. 
Cardiovasc Res 40:600-606, 1998 
107. Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA: Low birthweight is 
associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 
48:547-552, 2005 
108. Thompson CH, Sanderson AL, Sandeman D, Stein C, Borthwick A, Radda GK, Phillips DI: 
Fetal growth and insulin resistance in adult life: role of skeletal muscle morphology. Clin Sci 
(Lond) 92:291-296, 1997 
109. Taylor DJ, Thompson CH, Kemp GJ, Barnes PR, Sanderson AL, Radda GK, Phillips DI: A 
relationship between impaired fetal growth and reduced muscle glycolysis revealed by 31P 
magnetic resonance spectroscopy. Diabetologia 38:1205-1212, 1995 
110. Phillips DI: Relation of fetal growth to adult muscle mass and glucose tolerance. Diabet Med 
12:686-690, 1995 
111. Lapillonne A, Braillon P, Claris O, Chatelain PG, Delmas PD, Salle BL: Body composition in 
appropriate and in small for gestational age infants. Acta Paediatr 86:196-200, 1997 
112. Hediger ML, Overpeck MD, Kuczmarski RJ, McGlynn A, Maurer KR, Davis WW: 
Muscularity and fatness of infants and young children born small- or large-for-gestational-age. 
Pediatrics 102:E60, 1998 
113. Singhal A, Wells J, Cole TJ, Fewtrell M, Lucas A: Programming of lean body mass: a link 
between birth weight, obesity, and cardiovascular disease? Am J Clin Nutr 77:726-730, 2003 
114. Eriksson J, Forsén T, Tuomilehto J, Osmond C, Barker D: Size at birth, fat-free mass and 
resting metabolic rate in adult life. Horm Metab Res 34:72-76, 2002 
115. Gale CR, Martyn CN, Kellingray S, Eastell R, Cooper C: Intrauterine programming of adult 
body composition. J Clin Endocrinol Metab 86:267-272, 2001 
116. Sayer AA, Syddall HE, Dennison EM, Gilbody HJ, Duggleby SL, Cooper C, Barker DJ, 
Phillips DI: Birth weight, weight at 1 y of age, and body composition in older men: findings from 
the Hertfordshire Cohort Study. Am J Clin Nutr 80:199-203, 2004 
117. Kensara OA, Wootton SA, Phillips DI, Patel M, Jackson AA, Elia M: Fetal programming of 
body composition: relation between birth weight and body composition measured with dual-
energy X-ray absorptiometry and anthropometric methods in older Englishmen. Am J Clin Nutr 
82:980-987, 2005 
118. Dulloo AG, Jacquet J, Montani JP: Pathways from weight fluctuations to metabolic diseases: 
focus on maladaptive thermogenesis during catch-up fat. Int J Obes Relat Metab Disord 26 Suppl 
2:S46-57, 2002 
119. Levy-Marchal C, Jaquet D, Czernichow P: Long-term metabolic consequences of being born 
small for gestational age. Semin Neonatol 9:67-74, 2004 
 
85 
120. Martins PA, Hoffman DJ, Fernandes MT, Nascimento CR, Roberts SB, Sesso R, Sawaya AL: 
Stunted children gain less lean body mass and more fat mass than their non-stunted counterparts: a 
prospective study. Br J Nutr 92:819-825, 2004 
121. Dulloo AG, Jacquet J, Seydoux J, Montani JP: The thrifty 'catch-up fat' phenotype: its impact 
on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int J Obes 
(Lond) 30 Suppl 4:S23-35, 2006 
122. Reik W, Constancia M, Fowden A, Anderson N, Dean W, Ferguson-Smith A, Tycko B, 
Sibley C: Regulation of supply and demand for maternal nutrients in mammals by imprinted 
genes. J Physiol 547:35-44, 2003 
123. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD: Fetal origins of 
hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J 
Physiol Endocrinol Metab 279:E83-87, 2000 
124. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its 
complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a 
WHO consultation. Diabet Med 15:539-553, 1998 
125. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 365:1415-1428, 2005 
126. Eriksson J, Forsén T, Tuomilehto J, Osmond C, Barker D: Fetal and childhood growth and 
hypertension in adult life. Hypertension 36:790-794, 2000 
127. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD: Fetal and infant 
growth and impaired glucose tolerance at age 64. Bmj 303:1019-1022, 1991 
128. Yarbrough DE, Barrett-Connor E, Kritz-Silverstein D, Wingard DL: Birth weight, adult 
weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho 
Bernardo Study. Diabetes Care 21:1652-1658, 1998 
129. Kajantie E, Barker DJ, Osmond C, Forsen T, Eriksson JG: Growth before 2 years of age and 
serum lipids 60 years later: the Helsinki Birth Cohort Study. Int J Epidemiol, 2008 
130. Laaksonen DE, Lakka HM, Lynch J, Lakka TA, Niskanen L, Rauramaa R, Salonen JT, 
Kauhanen J: Cardiorespiratory fitness and vigorous leisure-time physical activity modify the 
association of small size at birth with the metabolic syndrome. Diabetes Care 26:2156-2164, 2003 
131. Ramadhani MK, Grobbee DE, Bots ML, Castro Cabezas M, Vos LE, Oren A, Uiterwaal CS: 
Lower birth weight predicts metabolic syndrome in young adults: the Atherosclerosis Risk in 
Young Adults (ARYA)-study. Atherosclerosis 184:21-27, 2006 
132. de Rooij SR, Painter RC, Holleman F, Bossuyt PM, Roseboom TJ: The metabolic syndrome 
in adults prenatally exposed to the Dutch famine. Am J Clin Nutr 86:1219-1224, 2007 
133. te Velde SJ, Twisk JW, van Mechelen W, Kemper HC: A birth-weight questionnaire 
indicated that life style modifies the birth weight and metabolic syndrome relationship at age 36. J 
Clin Epidemiol 58:1172-1179, 2005 
134. Parker L, Lamont DW, Unwin N, Pearce MS, Bennett SM, Dickinson HO, White M, Mathers 
JC, Alberti KG, Craft AW: A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and 
obesity (the central metabolic syndrome) at age 49-51 years. Diabet Med 20:406-415, 2003 
 
86 
135. Vanhala MJ, Vanhala PT, Keinanen-Kiukaanniemi SM, Kumpusalo EA, Takala JK: Relative 
weight gain and obesity as a child predict metabolic syndrome as an adult. Int J Obes Relat Metab 
Disord 23:656-659, 1999 
136. Huang TT, Nansel TR, Belsheim AR, Morrison JA: Sensitivity, specificity, and predictive 
values of pediatric metabolic syndrome components in relation to adult metabolic syndrome: the 
Princeton LRC follow-up study. J Pediatr 152:185-190, 2008 
137. Fagerberg B, Bondjers L, Nilsson P: Low birth weight in combination with catch-up growth 
predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis 
and Insulin Resistance study. J Intern Med 256:254-259, 2004 
138. Morrison JA, Friedman LA, Wang P, Glueck CJ: Metabolic syndrome in childhood predicts adult 
metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 152:201-206, 2008 
139. Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J: Relation between obesity from 
childhood to adulthood and the metabolic syndrome: population based study. Bmj 317:319, 1998 
140. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS: Relationship of childhood 
obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 
108:712-718, 2001 
141. Rolland-Cachera MF, Deheeger M, Bellisle F, Sempe M, Guilloud-Bataille M, Patois E: 
Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr 39:129-
135, 1984 
142. Dietz WH: Critical periods in childhood for the development of obesity. Am J Clin Nutr 
59:955-959, 1994 
143. Eriksson J, Forsén T, Osmond C, Barker D: Obesity from cradle to grave. Int J Obes Relat 
Metab Disord 27:722-727, 2003 
144. Bouhours-Nouet N, Dufresne S, de Casson FB, Mathieu E, Douay O, Gatelais F, Rouleau S, 
Coutant R: High birth weight and early postnatal weight gain protect obese children and 
adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese 
subjects? Diabetes Care 31:1031-1036, 2008 
145. Law CM, Shiell AW: Is blood pressure inversely related to birth weight? The strength of 
evidence from a systematic review of the literature. J Hypertens 14:935-941, 1996 
146. Huxley RR, Shiell AW, Law CM: The role of size at birth and postnatal catch-up growth in 
determining systolic blood pressure: a systematic review of the literature. J Hypertens 18:815-831, 2000 
147. Tu YK, West R, Ellison GT, Gilthorpe MS: Why evidence for the fetal origins of adult 
disease might be a statistical artifact: the "reversal paradox" for the relation between birth weight 
and blood pressure in later life. Am J Epidemiol 161:27-32, 2005 
148. Schluchter MD: Publication bias and heterogeneity in the relationship between systolic blood 
pressure, birth weight, and catch-up growth--a meta analysis. J Hypertens 21:273-279, 2003 
149. Cruickshank JK, Beith C, Koudsi A: Unravelling the fetal origins hypothesis. Lancet 
360:2073-2074; author reply 2074-2075, 2002 
 
87 
150. Barker DJ, Eriksson JG, Forsen T, Osmond C: Fetal origins of adult disease: strength of 
effects and biological basis. Int J Epidemiol 31:1235-1239, 2002 
151. Eriksson JG, Forsen T: Unravelling the fetal origins hypothesis. Lancet 360:2072; author 
reply 2074-2075, 2002 
152. Järvelin MR, Sovio U, King V, Lauren L, Xu B, McCarthy MI, Hartikainen AL, Laitinen J, 
Zitting P, Rantakallio P, Elliott P: Early life factors and blood pressure at age 31 years in the 1966 
northern Finland birth cohort. Hypertension 44:838-846, 2004 
153. Hardy R, Sovio U, King VJ, Skidmore PM, Helmsdal G, Olsen SF, Emmett PM, Wadsworth 
ME, Jarvelin MR: Birthweight and blood pressure in five European birth cohort studies: an 
investigation of confounding factors. Eur J Public Health 16:21-30, 2006 
154. Law CM, de Swiet M, Osmond C, Fayers PM, Barker DJ, Cruddas AM, Fall CH: Initiation of 
hypertension in utero and its amplification throughout life. Bmj 306:24-27, 1993 
155. Hardy R, Kuh D, Langenberg C, Wadsworth ME: Birthweight, childhood social class, and 
change in adult blood pressure in the 1946 British birth cohort. Lancet 362:1178-1183, 2003 
156. Koupil I, Leon DA, Byberg L: Birth weight, hypertension and "white coat" hypertension: size at 
birth in relation to office and 24-h ambulatory blood pressure. J Hum Hypertens 19:635-642, 2005 
157. Lackland DT, Egan BM, Syddall HE, Barker DJ: Associations between birth weight and 
antihypertensive medication in black and white medicaid recipients. Hypertension 39:179-183, 2002 
158. Cole TJ: Modeling postnatal exposures and their interactions with birth size. J Nutr 134:201-
204, 2004 
159. Head RF, Tu YK, Gilthorpe MS, Mishra GD, Williams S, Ellison GT: What evidence is there 
that adjustment for adult height influences the relationship between birth weight and blood 
pressure? Ann Hum Biol 34:252-264, 2007 
160. Stumvoll M, Häring H: The peroxisome proliferator-activated receptor-gamma2 Pro12Ala 
polymorphism. Diabetes 51:2341-2347, 2002 
161. Debril MB, Renaud JP, Fajas L, Auwerx J: The pleiotropic functions of peroxisome 
proliferator-activated receptor gamma. J Mol Med 79:30-47, 2001 
162. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, 
Shuldiner AR: Molecular scanning of the human peroxisome proliferator activated receptor 
gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 
2 missense mutation. Biochem Biophys Res Commun 241:270-274, 1997 
163. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto 
W, Auwerx J: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor 
activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287, 1998 
164. Eriksson JG, Lindi V, Uusitupa M, Forsén TJ, Laakso M, Osmond C, Barker DJ: The effects 
of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on 
insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 51:2321-2324, 2002 
 
88 
165. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic 
association studies supports a contribution of common variants to susceptibility to common 
disease. Nat Genet 33:177-182, 2003 
166. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, 
Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES: 
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 
diabetes. Nat Genet 26:76-80, 2000 
167. Meirhaeghe A, Amouyel P: Impact of genetic variation of PPARgamma in humans. Mol 
Genet Metab 83:93-102, 2004 
168. Tönjes A, Scholz M, Loeffler M, Stumvoll M: Association of Pro12Ala polymorphism in 
peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 
57 studies on nondiabetic individuals. Diabetes Care 29:2489-2497, 2006 
169. Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M, Marini MA, 
Andreozzi F, Vaccaro O, Sesti G, Trischitta V: Heterogeneous effect of peroxisome proliferator-
activated receptor gamma2 Ala12 variant on type 2 diabetes risk. Obesity (Silver Spring) 15:1076-
1081, 2007 
170. Stumvoll M, Stefan N, Fritsche A, Madaus A, Tschritter O, Koch M, Machicao F, Haring H: 
Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin 
receptor substrate 1 (Gly972Arg) on insulin sensitivity. J Mol Med 80:33-38, 2002 
171. Jaquet D, Tregouet DA, Godefroy T, Nicaud V, Chevenne D, Tiret L, Czernichow P, Levy-
Marchal C, Gaboriau A: Combined effects of genetic and environmental factors on insulin 
resistance associated with reduced fetal growth 
Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. 
Diabetes 51:3473-3478, 2002 
172. Bosse Y, Weisnagel SJ, Bouchard C, Despres JP, Perusse L, Vohl MC: Combined effects of 
PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: 
the Quebec Family Study. J Hum Genet 48:614-621, 2003 
173. Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ: Does 
peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of 
physical activity and dietary fat with fasting insulin level? Metabolism 53:11-16, 2004 
174. de Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Defesche JC, Bossuyt PM, 
Michels RP, Bleker OP, Roseboom TJ: The effects of the Pro12Ala polymorphism of the 
peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact 
with prenatal exposure to famine. Diabetes Care 29:1052-1057, 2006 
175. Knouff C, Auwerx J: Peroxisome proliferator-activated receptor-gamma calls for activation in 
moderation: lessons from genetics and pharmacology. Endocr Rev 25:899-918, 2004 
176. Hasstedt SJ, Ren QF, Teng K, Elbein SC: Effect of the peroxisome proliferator-activated 
receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in 
members of familial type 2 diabetic kindreds. J Clin Endocrinol Metab 86:536-541, 2001 
 
89 
177. Ostgren CJ, Lindblad U, Melander O, Melander A, Groop L, Råstam L: Peroxisome 
proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood 
pressure in type 2 diabetes: skaraborg hypertension and diabetes project. J Hypertens 21:1657-
1662, 2003 
178. Stefanski A, Majkowska L, Ciechanowicz A, Frankow M, Safranow K, Parczewski M, 
Moleda P, Pilarska K: Association between the Pro12Ala variant of the peroxisome proliferator-
activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with 
type II diabetes. J Hum Hypertens 20:684-692, 2006 
179. Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi 
G: Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome 
proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals. Clin Endocrinol (Oxf) 
57:481-486, 2002 
180. Gouni-Berthold I, Giannakidou E, Muller-Wieland D, Faust M, Kotzka J, Berthold HK, 
Krone W: Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric 
oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus 
type 2. J Hypertens 23:301-308, 2005 
181. Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A, Alamo-Santana F: 
Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide 
synthase-4a/bgene polymorphisms are associated with essential hypertension. J Hypertens 
21:1649-1655, 2003 
182. Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A: Birth weight and 
subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 165:849-857, 2007 
183. Silverman BL, Metzger BE, Cho NH, Loeb CA: Impaired glucose tolerance in adolescent offspring 
of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 18:611-617, 1995 
184. Lakka TA, Laaksonen DE: Physical activity in prevention and treatment of the metabolic 
syndrome. Appl Physiol Nutr Metab 32:76-88, 2007 
185. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, 
Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: 
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired 
glucose tolerance. N Engl J Med 344:1343-1350, 2001 
186. Boreham CA, Murray L, Dedman D, Davey Smith G, Savage JM, Strain JJ: Birthweight and 
aerobic fitness in adolescents: the Northern Ireland Young Hearts Project. Public Health 115:373-
379, 2001 
187. Demura S, Sato S, Kitabayashi T: Percentage of total body fat as estimated by three 
automatic bioelectrical impedance analyzers. J Physiol Anthropol Appl Human Sci 23:93-99, 2004 
188. Charney E, Goodman HC, McBride M, Lyon B, Pratt R: Childhood antecedents of adult 
obesity. Do chubby infants become obese adults? N Engl J Med 295:6-9, 1976 
189. Oken E, Gillman MW: Fetal origins of obesity. Obes Res 11:496-506, 2003 
 
90 
190. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ: Birth weight 
and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 94:3246-3250, 1996 
191. Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE, Speizer FE, 
Stampfer MJ: Birth weight and adult hypertension and obesity in women. Circulation 94:1310-
1315, 1996 
192. Rasmussen F, Johansson M: The relation of weight, length and ponderal index at birth to 
body mass index and overweight among 18-year-old males in Sweden. Eur J Epidemiol 14:373-
380, 1998 
193. Eriksson JG, Forsén TJ, Osmond C, Barker DJ: Pathways of infant and childhood growth that 
lead to type 2 diabetes. Diabetes Care 26:3006-3010, 2003 
194. Eriksson JG, Forsén T, Tuomilehto J, Jaddoe VW, Osmond C, Barker DJ: Effects of size at 
birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia 
45:342-348, 2002 
195. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C: Insulin resistance early in adulthood in 
subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 85:1401-1406, 2000 
196. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C: Thinness at birth and insulin resistance 
in adult life. Diabetologia 37:150-154, 1994 
197. Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V, Bhave S, Kellingray 
SD, Joglekar C: Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 
years, or both? Diabetes 48:2422-2429, 1999 
198. Ong KK, Dunger DB: Birth weight, infant growth and insulin resistance. Eur J Endocrinol 
151 Suppl 3:U131-139, 2004 
199. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniguez G, Ong KK, Dunger DB, Mericq MV: 
Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at 
age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 88:3645-3650, 2003 
200. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA: Glucose tolerance, 
insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin 
Endocrinol Metab 87:4657-4661, 2002 
201. Whincup PH, Cook DG, Adshead F, Taylor SJ, Walker M, Papacosta O, Alberti KG: 
Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11-
year-old children. Diabetologia 40:319-326, 1997 
202. Byberg L, McKeigue PM, Zethelius B, Lithell HO: Birth weight and the insulin resistance 
syndrome: association of low birth weight with truncal obesity and raised plasminogen activator 
inhibitor-1 but not with abdominal obesity or plasma lipid disturbances. Diabetologia 43:54-60, 2000 
203. Garnett SP, Cowell CT, Baur LA, Fay RA, Lee J, Coakley J, Peat JK, Boulton TJ: Abdominal 
fat and birth size in healthy prepubertal children. Int J Obes Relat Metab Disord 25:1667-1673, 2001 
204. Kuh D, Hardy R, Chaturvedi N, Wadsworth ME: Birth weight, childhood growth and 
abdominal obesity in adult life. Int J Obes Relat Metab Disord 26:40-47, 2002 
 
91 
205. Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ: Early growth and abdominal fatness 
in adult life. J Epidemiol Community Health 46:184-186, 1992 
206. Rogers IS, Ness AR, Steer CD, Wells JC, Emmett PM, Reilly JR, Tobias J, Smith GD: 
Associations of size at birth and dual-energy X-ray absorptiometry measures of lean and fat mass 
at 9 to 10 y of age. Am J Clin Nutr 84:739-747, 2006 
207. Hng TM, McLean M, Cheung NW, Thompson CH: The interrelation of birth weight and 
regional lipid deposition: a twins study. Metabolism 55:561-562, 2006 
208. Ibáñez L, Ong K, Dunger DB, de Zegher F: Early Development of Adiposity and Insulin 
Resistance Following Catch-up Weight Gain in Small-for-Gestational-Age Children. J Clin 
Endocrinol Metab, 2006 
209. Wells JC, Hallal PC, Wright A, Singhal A, Victora CG: Fetal, infant and childhood growth: 
relationships with body composition in Brazilian boys aged 9 years. Int J Obes Relat Metab 
Disord, 2005 
210. Li H, Stein AD, Barnhart HX, Ramakrishnan U, Martorell R: Associations between prenatal 
and postnatal growth and adult body size and composition. Am J Clin Nutr 77:1498-1505, 2003 
211. Ekelund U, Ong K, Linne Y, Neovius M, Brage S, Dunger DB, Wareham NJ, Rossner S: 
Upward weight percentile crossing in infancy and early childhood independently predicts fat mass 
in young adults: the Stockholm Weight Development Study (SWEDES). Am J Clin Nutr 83:324-
330, 2006 
212. Sachdev HS, Fall CH, Osmond C, Lakshmy R, Dey Biswas SK, Leary SD, Reddy KS, Barker 
DJ, Bhargava SK: Anthropometric indicators of body composition in young adults: relation to size 
at birth and serial measurements of body mass index in childhood in the New Delhi birth cohort. 
Am J Clin Nutr 82:456-466, 2005 
213. Victora CG, Sibbritt D, Horta BL, Lima RC, Cole T, Wells J: Weight gain in childhood and 
body composition at 18 years of age in Brazilian males. Acta Paediatr 96:296-300, 2007 
214. Lakka TA, Salonen JT: Intra-person variability of various physical activity assessments in the 
Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol 21:467-472, 1992 
215. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and 
its complications: report of a WHO consultation: Part 1. Diagnosis and classification of diabetes 
mellitus. Geneva, World Health Organization, 1999 
216. Bedogni G, Malavolti M, Severi S, Poli M, Mussi C, Fantuzzi AL, Battistini N: Accuracy of 
an eight-point tactile-electrode impedance method in the assessment of total body water. Eur J 
Clin Nutr 56:1143-1148, 2002 
217. Malavolti M, Mussi C, Poli M, Fantuzzi AL, Salvioli G, Battistini N, Bedogni G: Cross-
calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray 
absorptiometry for the assessment of total and appendicular body composition in healthy subjects 
aged 21-82 years. Ann Hum Biol 30:380-391, 2003 
 
92 
218. Sartorio A, Malavolti M, Agosti F, Marinone PG, Caiti O, Battistini N, Bedogni G: Body 
water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance 
analysis. Eur J Clin Nutr 59:155-160, 2005 
219. Gibson AL, Holmes JC, Desautels RL, Edmonds LB, Nuudi L: Ability of new octapolar 
bioimpedance spectroscopy analyzers to predict 4-component-model percentage body fat in 
Hispanic, black, and white adults. Am J Clin Nutr 87:332-338, 2008 
220. Gale CR, O'Callaghan FJ, Bredow M, Martyn CN: The influence of head growth in fetal life, 
infancy, and childhood on intelligence at the ages of 4 and 8 years. Pediatrics 118:1486-1492, 2006 
221. VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA: Height-normalized indices 
of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J 
Clin Nutr 52:953-959, 1990 
222. Wells JC: A critique of the expression of paediatric body composition data. Arch Dis Child 
85:67-72, 2001 
223. World Health Organization. The WHO Child Growth Standards. In Internet: 
http://www.who.int/childgrowth/standards/en/ (accessed May 2007) 
224. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child 
overweight and obesity worldwide: international survey. Bmj 320:1240-1243, 2000 
225. Koupilova I, Leon DA, McKeigue PM, Lithell HO: Is the effect of low birth weight on 
cardiovascular mortality mediated through high blood pressure? J Hypertens 17:19-25, 1999 
226. Merlet-Benichou C LB, Gilbert T, Lelievre-Pegorier M: Retard de croissance intra-uterin et 
deficit en nephrons [Intrauterine growth retardation and inborn nephron deficit]. 
Medecine/Sciences 9:777-780, 1993 
227. Martyn CN, Greenwald S.E.: Mechanisms for in-utero programming of blood pressure. In Fetal 
origins of cardiovascular and lung disease, Barker, DJP ed. New York, Marcel Dekker, 2001 
228. Nickenig G, Röling J, Strehlow K, Schnabel P, Böhm M: Insulin induces upregulation of 
vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 98:2453-
2460, 1998 
229. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR: Cross-talk between the insulin 
and angiotensin signaling systems. Proc Natl Acad Sci U S A 93:12490-12495, 1996 
230. Velloso LA, Folli F, Perego L, Saad MJ: The multi-faceted cross-talk between the insulin and 
angiotensin II signaling systems. Diabetes Metab Res Rev 22:98-107, 2006 
231. Sherman RC, Langley-Evans SC: Early administration of angiotensin-converting enzyme 
inhibitor captopril, prevents the development of hypertension programmed by intrauterine 
exposure to a maternal low-protein diet in the rat. Clin Sci (Lond) 94:373-381, 1998 
232. Hattersley AT, Tooke JE: The fetal insulin hypothesis: an alternative explanation of the 
association of low birthweight with diabetes and vascular disease. Lancet 353:1789-1792, 1999 
233. Pihlajamäki J, Vanhala M, Vanhala P, Laakso M: The Pro12Ala polymorphism of the PPAR 
gamma 2 gene regulates weight from birth to adulthood. Obes Res 12:187-190, 2004 
 
93 
234. Pfab T, Poralla C, Richter CM, Godes M, Slowinski T, Priem F, Halle H, Hocher B: Fetal and 
maternal peroxisome proliferator-activated receptor gamma2 Pro12Ala does not influence birth 
weight. Obesity (Silver Spring) 14:1880-1885, 2006 
235. Eriksson JG, Lindi V, Uusitupa M, Forsen TJ, Laakso M, Osmond C, Barker DJ: The effects 
of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on 
insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 51:2321-2324, 2002 
236. Hermann TS, Rask-Madsen C, Ihlemann N, Dominguez H, Jensen CB, Storgaard H, Vaag 
AA, Kober L, Torp-Pedersen C: Normal insulin-stimulated endothelial function and impaired 
insulin-stimulated muscle glucose uptake in young adults with low birth weight. J Clin Endocrinol 
Metab 88:1252-1257, 2003 
237. Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, Rosner B, 
Hennekens CH, Speizer FE: Physical activity and incidence of non-insulin-dependent diabetes 
mellitus in women. Lancet 338:774-778, 1991 
238. Eriksson JG: Exercise and the treatment of type 2 diabetes mellitus. An update. Sports Med 
27:381-391, 1999 
239. Gill JM, Malkova D: Physical activity, fitness and cardiovascular disease risk in adults: 
interactions with insulin resistance and obesity. Clin Sci (Lond) 110:409-425, 2006 
240. Sun SS, Liang R, Huang TT, Daniels SR, Arslanian S, Liu K, Grave GD, Siervogel RM: 
Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. J Pediatr 
152:191-200, 2008 
241. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, 
Lupien PJ: Waist circumference and abdominal sagittal diameter: best simple anthropometric 
indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men 
and women. Am J Cardiol 73:460-468, 1994 
242. Sternfeld B, Ngo L, Satariano WA, Tager IB: Associations of body composition with 
physical performance and self-reported functional limitation in elderly men and women. Am J 
Epidemiol 156:110-121, 2002 
243. Kuh D, Bassey J, Hardy R, Aihie Sayer A, Wadsworth M, Cooper C: Birth weight, childhood 
size, and muscle strength in adult life: evidence from a birth cohort study. Am J Epidemiol 
156:627-633, 2002 
244. Sayer AA, Syddall HE, Gilbody HJ, Dennison EM, Cooper C: Does sarcopenia originate in 
early life? Findings from the Hertfordshire cohort study. J Gerontol A Biol Sci Med Sci 59:M930-
934, 2004 
245. Lawlor DA, Davey Smith G, Ebrahim S: Life course influences on insulin resistance: 
findings from the British Women's Heart and Health Study. Diabetes Care 26:97-103, 2003 
246. Hypponen E, Power C, Smith GD: Prenatal growth, BMI, and risk of type 2 diabetes by early 
midlife. Diabetes Care 26:2512-2517, 2003 
247. Stein AD, Thompson AM, Waters A: Childhood growth and chronic disease: evidence from 
countries undergoing the nutrition transition. Matern Child Nutr 1:177-184, 2005 
 
94 
248. Rosen ED, Spiegelman BM: Adipocytes as regulators of energy balance and glucose 
homeostasis. Nature 444:847-853, 2006 
249. Baird J, Fisher D, Lucas P, Kleijnen J, Roberts H, Law C: Being big or growing fast: 
systematic review of size and growth in infancy and later obesity. Bmj 331:929, 2005 
250. Monteiro PO, Victora CG: Rapid growth in infancy and childhood and obesity in later life--a 
systematic review. Obes Rev 6:143-154, 2005 
251. Stettler N, Zemel BS, Kumanyika S, Stallings VA: Infant weight gain and childhood 
overweight status in a multicenter, cohort study. Pediatrics 109:194-199, 2002 
252. Demerath EW, Schubert CM, Maynard LM, Sun SS, Chumlea WC, Pickoff A, Czerwinski 
SA, Towne B, Siervogel RM: Do changes in body mass index percentile reflect changes in body 
composition in children? Data from the Fels Longitudinal Study. Pediatrics 117:e487-495, 2006 
253. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET: Metabolic and body 
composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89:2569-
2575, 2004 
254. Després JP: Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and 
cardiovascular disease. J Endocrinol Invest 29:77-82, 2006 
255. Salmenniemi U, Ruotsalainen E, Vanttinen M, Vauhkonen I, Pihlajamaki J, Kainulainen S, 
Punnonen K, Laakso M: High amount of visceral fat mass is associated with multiple metabolic 
changes in offspring of type 2 diabetic patients. Int J Obes (Lond) 29:1464-1470, 2005 
256. Syddall H, Cooper C, Martin F, Briggs R, Aihie Sayer A: Is grip strength a useful single 
marker of frailty? Age Ageing 32:650-656, 2003 
257. Population ageing: a looming public health challenge. Health Millions 24:20-22, 1998 
258. Broadwin J, Goodman-Gruen D, Slymen D: Ability of fat and fat-free mass percentages to 
predict functional disability in older men and women. J Am Geriatr Soc 49:1641-1645, 2001 
259. Heitmann BL, Erikson H, Ellsinger BM, Mikkelsen KL, Larsson B: Mortality associated with 
body fat, fat-free mass and body mass index among 60-year-old swedish men-a 22-year follow-up. 
The study of men born in 1913. Int J Obes Relat Metab Disord 24:33-37, 2000 
260. Strawbridge WJ, Cohen RD, Shema SJ, Kaplan GA: Successful aging: predictors and 
associated activities. Am J Epidemiol 144:135-141, 1996 
261. Wells JC, Coward WA, Cole TJ, Davies PS: The contribution of fat and fat-free tissue to 
body mass index in contemporary children and the reference child. Int J Obes Relat Metab Disord 
26:1323-1328, 2002 
262. Gallagher D, Ruts E, Visser M, Heshka S, Baumgartner RN, Wang J, Pierson RN, Pi-Sunyer 
FX, Heymsfield SB: Weight stability masks sarcopenia in elderly men and women. Am J Physiol 
Endocrinol Metab 279:E366-375, 2000 
 
